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ABSTRACT 
Background 
Stroke is a leading cause of death and disability worldwide. In addition cognitive impairment 
(and dementia) and depression are common sequelae. Additional assessment methods which 
would better inform early prognostication of these unfavourable outcomes would engender 
substantial clinical benefits. For example, more accurate prognostication would enhance 
clinical decisions regarding appropriate levels of rehabilitation or care. This thesis 
investigates the potential utility, in this context, of one such assessment methodology; 
quantitative EEG (QEEG), performed in the first days after stroke. 
 
Study 1 (Chapter 2) 
The primary aim was to investigate the relationship between post-stroke QEEG measures and 
cognitive outcomes. Resting-state EEG was recorded within 62–101h after onset of middle 
cerebral artery (MCA) territory, ischaemic stroke. QEEG indices sensitive to power of one or 
more frequency bands were computed. The functional independence measure and functional 
assessment measure (FIM–FAM) was administered at approximately 3-months post-stroke. 
Total (30 items) and cognition-specific (5 items) FIM–FAM scores were correlated with 
QEEG indices using Spearman's coefficient.  
 
Twenty cases (10 female; age range 38–84) were analysed. Two QEEG indices demonstrated 
highly-significant correlations with cognitive outcomes: relative alpha power across the scalp 
(ρ=0.67, p≤0.001) and frontal delta/alpha power ratio (ρ=−0.664, p≤0.001). These results 
demonstrate that QEEG measures are associated with cognitive outcomes, and may 
potentially inform prognostication of same. 
 
Study 2 (Chapter 3) 
The primary aim was to investigate the ability of QEEG indices to inform prognostication of 
cognitive outcomes, assessed using the Montreal Cognitive Assessment (MoCA). Resting-
state EEG was recorded within 48-239h after stroke symptom onset.   Various QEEG indices 
analysed across the scalp were calculated. The MoCA was administered at approximately 3-
months post-stroke and scores correlated with QEEG indices using Spearman's coefficient. 
Binary logistic regression was employed, with cognitive impairment indicated by MoCA 
scores ≤25. 
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Thirty-one participants (10 female, age range: 18-84) were included in the analyses.  Two 
measures of alpha frequency slowing (relative power in the traditional upper theta frequency 
range in posterior regions and peak alpha frequency across frontal and posterior regions of 
the scalp) were significantly positively correlated with lower MoCA scores. Using regression 
analysis, relative power of slowed alpha activity from 2 posterior regions were selected as 
optimal predictors of cognitive impairment. The regression model utilising these QEEG 
measures was able to accurately prognosticate cognitive impairment outcomes in 81% of the 
participants (25/31). These results indicate that the power of slowed alpha activity, acquired 
within several days of stroke onset from several electrodes only, can inform early 
prognostication of post-stroke cognitive outcomes.   This QEEG measure would be of clinical 
value given the substantial numbers of stroke patients whom are unable to complete cognitive 
assessments, such as the MoCA, prior to hospital discharge due to functional impairments (as 
was the case in 13% of the patients recruited in the study). 
 
Study 3 (Chapter 4) 
The aim of the final study was to investigate potential associations between pre-discharge 
QEEG indices and post-stroke depression (PSD) outcome measures as well as the ability of 
QEEG to inform prognostication of PSD. (Methodology is detailed in Study 2, above). 
Outcome was assessed using the Geriatric Depression Scale (GDS) at approximately 3-
months post-stroke.  GDS scores were correlated with QEEG indices using Spearman's 
coefficient. Binary logistic regression was used to build a QEEG model to classify 
depression, indicated by GDS scores ≤6 (out of 15). 
 
A significant correlation was obtained between PSD and an index of interhemispheric 
asymmetry of delta activity, patients with more symmetric delta activity tended to have 
higher GDS scores (r=-0.475, p=0.007, n=31).  This variable was entered into the binary 
logistic regression model, however, it was not found to be a statistically significant predictor 
of subsequent PSD.  
 
Conclusions 
The results of the studies reported in Chapters 2 and 3 collectively indicate that QEEG 
markers sensitive to alpha activity – particularly alpha slowing – following ischaemic stroke 
can inform early prognoses regarding post-stroke cognitive impairment. Notably, pre-
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discharge measures of slowed alpha activity, from several electrodes only, was found to 
reliably predict cognitive outcomes in the majority of patients investigated. Importantly, 
virtually all patients can be assessed with EEG, including the substantial proportion of 
patients who cannot be assessed with more routine assessment scales such as the MoCA; 
hence QEEG would be of particular clinical value in such cases.  It is postulated that the 
observed associations between post-stroke measures of alpha slowing and cognitive outcomes 
are reflective of attentional function which appears linked to both variables. These novel 
findings and interpretations constitute the principal contributions of this thesis to the 
knowledge base in this field.  In summary this research has considerable potential to 
ultimately contribute towards enhanced care and benefits for stroke patients and the broader 
community.  
iv 
DECLARATION BY AUTHOR 
This thesis is composed of my original work, and contains no material previously published 
or written by another person except where due reference has been made in the text. I have 
clearly stated the contribution by others to jointly-authored works that I have included in my 
thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional 
editorial advice, and any other original research work used or reported in my thesis. The 
content of my thesis is the result of work I have carried out since the commencement of my 
research higher degree candidature and does not include a substantial part of work that has 
been submitted to qualify for the award of any other degree or diploma in any university or 
other tertiary institution. I have clearly stated which parts of my thesis, if any, have been 
submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the policy and procedures of The University of Queensland, the thesis 
be made available for research and study in accordance with the Copyright Act 1968 unless a 
period of embargo has been approved by the Dean of the Graduate School.  
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 
copyright holder to reproduce material in this thesis. 
 
v 
PUBLICATIONS DURING CANDIDATURE 
Peer-reviewed papers 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Frontal EEG 
delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four 
electrodes. International Journal of Psychophysiology. 2014; 94(1): 19-24. doi: 
10.1016/j.ijpsycho.2014.06.012 
 
Published Conference Abstracts 
 Schleiger E., Rowland T., Wong A., Read S. and Finnigan S. Informing prognostication of 
post-stroke cognitive impairment: The accuracy of a pre-discharge EEG marker. To be 
published in International Journal of Stroke. 2016, Conference Abstract: Stroke 2016. 
Brisbane 
 Schleiger E., Rowland T., Wong A., Read S. and Finnigan S. Early screening for post-
stroke cognitive deficits may be informed by degree of EEG alpha slowing. International 
Journal of Stroke. 2015, Conference Abstract: Stroke 2015. Melbourne, selected for oral 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Prognosticating 
post-stroke cognitive outcomes: pre-discharge, frontal EEG markers are informative.  
International Journal of Stroke. 2014, Conference Abstract: Stroke Society of Australasia. 
Hamilton Island, selected for oral 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Prognosticating 
post-stroke cognitive deficits from pre-discharge EEG. International Journal of Stroke. 
2013, Conference Abstract: Smart Strokes (9th Australasian Nursing & Allied Health 
Conference);8(Suppl.2);31. Brisbane 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Pre-discharge 
EEG markers are informative of post-stroke cognitive outcomes. International Journal of 
Stroke. 2013, Conference abstract: 24th Annual Scientific Meeting of the Stroke Society 
of Australasia;8(Suppl.1);21. Darwin, selected for oral 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Early post-stroke 
measures of slowed frontal lobe activity can help predict cognitive outcomes. Frontiers in 
Human Neuroscience. 2014, Conference Abstract: ICON-2014 International Conference 
on Cognitive Neuroscience, Brisbane 
vi 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Prognosticating 
post-stroke cognitive deficits from pre-discharge EEG. Frontiers in Human Neuroscience. 
2013, Conference Abstract: ACNS-2013 Australasian Cognitive Neuroscience Society 
Conference. doi: 10.3389/conf.fnhum.2013.212.00128. Melbourne, selected for oral 
 Schleiger E., Sheikh N., Rowland T., Read S., Wong A. and Finnigan S. Pre-discharge 
QEEG can inform prognoses of post-stroke cognitive impairments. Frontiers in Human 
Neuroscience. 2012, Conference Abstract: ACNS-2012 Australasian Cognitive 
Neuroscience Conference. doi:10.3389/conf.fnhum.2012.208.00180. Brisbane 
 
Symposium and conference abstracts 
 Schleiger E., Rowland T., Wong A., Read S. and Finnigan S. Accurate prognostication of 
post-stroke cognitive status using age and EEG alpha measures.  2015, poster presented at 
Royal Brisbane and Women’s Hospital Symposium, Brisbane 
 Rowland T., Schleiger E., Sheikh N., Wong A., Read S. and Finnigan S. Relationship 
between QEEG indices recorded within 72 hours post-stroke and cognitive outcome at 3 
months post stroke. 2014, Invited oral presentation at Royal Brisbane and Women’s 
Hospital Healthcare Symposium, Brisbane 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Frontal EEG 
delta/alpha ratio and screening for post-stroke cognitive deficits: the power of four 
electrodes. 2014, poster presented at Royal Brisbane and Women’s Hospital Symposium, 
Brisbane 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Screening for 
post-stroke cognitive deficits: the value of frontal EEG markers. 2014, poster presented at 
Australian Society for Medical Research Conference, Brisbane 
 Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Informing 
prognoses of post-stroke cognitive deficits: the value of pre-discharge, frontal EEG 
measure. 2013, poster presented at Royal Brisbane Hospital Healthcare Symposium, 
Brisbane 
 Schleiger E., Finnigan S., Miller S., Bjorkman T. Investigating the efficacy of acute 
physiological measures to predict regional brain injury following neonatal hypoxia-
ischaemia. 2012, poster presented at Royal Brisbane Hospital Healthcare Symposium. 
Brisbane 
vii 
 Schleiger, E., Sheikh, N., Rowland, T., Wong, A., Read, S., Finnigan, S., 2014. Frontal 
EEG delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four 
electrodes. Int. J. Psychophysiol. 94, 19-24 
  
viii 
PUBLICATIONS INCLUDED IN THIS THESIS 
Publication incorporated as Chapter 2: Investigations into frontal QEEG indices and 
cognitive deficits following stroke 
Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Frontal EEG 
delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four 
electrodes. International Journal of Psychophysiology. 2014; 94(1): 19-24. doi: 
10.1016/j.ijpsycho.2014.06.012 
 
Contributor Statement of contribution 
Author 1: Emma Schleiger (Candidate) Designed experiments and collected data 
(50%) 
Statistical Analysis (100%) 
Wrote the paper (100%) 
Author 2 Nabeel Sheikh Designed experiments and collected data 
(40%) 
Author 3 Tennille Rowland Designed experiments and collected data 
(10%) 
Advised on and edited paper (10%) 
Author 4Andrew Wong Advised on and edited paper (15%) 
Author 5 Stephen Read Advised on and edited paper (15%) 
Author 6 Simon Finnigan (Principal Advisor) Advised on and edited paper (60%) 
EEG processing (100%) 
 
ix 
CONTRIBUTIONS BY OTHERS TO THE THESIS 
No contributions by others. 
 
STATEMENT OF PARTS OF THE THESIS SUBMITTED TO QUALIFY FOR THE 
AWARD OF ANOTHER DEGREE 
None. 
 
x 
ACKNOWLEDGEMENTS 
Firstly I would like to thank my three supervisors Simon Finnigan, Andrew Wong and 
Stephen Read.  In particular, special thanks must be given to Simon who over the past 5 years 
has gone above and beyond as a supervisor and mentor.  Your guidance and advice, even 
your perfectionist tendencies and high expectations, have given me a standard to work 
towards throughout my career.  In addition I would like to thank Andrew for his 
knowledgeable opinion on all things stroke related and for his support at the RBWH stroke 
unit.  You expertly juggle the duties of a busy consultant, director and supervisor and have 
given your time generously.  Thanks to Stephen for coming into the RBWH for meetings and 
presentations and your valuable contributions to the planning of this project and thesis. 
 
I would be remiss not to mention Tennille Rowland in my acknowledgements; Tennille has 
operated as an unofficial supervisor and mentor throughout this project.  Not only is Tennille 
incredibly knowledgeable about all things stroke and OT, she has been a welcoming, kind 
and patient colleague at the RBWH and helped invaluably with the identification and 
recruitment of patients.  The staff at the RBWH stroke unit, in particular Genevieve Skinner, 
have been fantastic and welcoming throughout the past several years and I need to thank 
them for their generous support of my research.  Importantly, I need to thank the stroke 
patients who generously gave their time to participate in this project.  Hearing your stories 
and thoughts while I apply electrodes to has been a true highlight of this research project. 
 
Thank you to the Royal Brisbane and Women’s Hospital Foundation for their financial 
support throughout my candidature through a generous 3 year research scholarship.   
 
Lastly to my non-science support team; thanks to my partner Matt for his patience and 
support over the past 5 years and for understanding that worthwhile endeavours often require 
sacrifice.  Thanks to my Mum, Dad, Kitty and David for the general cheerleading, draft 
reading and advice, all of your support and encouragement has been heartfelt and much 
appreciated. 
xi 
KEYWORDS 
Electroencephalography, QEEG, stroke, cognitive impairment, cognitive screening, alpha 
power, alpha slowing, MoCA, post-stroke depression, screening 
 
AUSTRALIAN AND NEW ZEALAND STANDARD RESEARCH 
CLASSIFICATIONS (ANZSRC) 
ANZSRC code: 170205 Neurocognitive Patterns and Neural Networks 60% 
ANZSRC code: 170299 Cognitive Sciences not elsewhere classified 40% 
 
FIELDS OF RESEARCH (FOR) CLASSIFICATION 
FoR code: 1109 Neurosciences 50% 
FoR code: 1103 Clinical Sciences 50% 
 
1 
TABLE OF CONTENTS 
ABSTRACT ......................................................................................................................................... i 
DECLARATION BY AUTHOR ..................................................................................................... iv 
PUBLICATIONS DURING CANDIDATURE ............................................................................... v 
Peer-reviewed papers ..................................................................................................................................... v 
Published Conference Abstracts .................................................................................................................... v 
Symposium and conference abstracts ........................................................................................................... vi 
PUBLICATIONS INCLUDED IN THIS THESIS ...................................................................... viii 
CONTRIBUTIONS BY OTHERS TO THE THESIS ................................................................... ix 
STATEMENT OF PARTS OF THE THESIS SUBMITTED TO QUALIFY FOR THE 
AWARD OF ANOTHER DEGREE ............................................................................................... ix 
ACKNOWLEDGEMENTS............................................................................................................... x 
KEYWORDS ..................................................................................................................................... xi 
AUSTRALIAN AND NEW ZEALAND STANDARD RESEARCH CLASSIFICATIONS 
(ANZSRC) ......................................................................................................................................... xi 
FIELDS OF RESEARCH (FOR) CLASSIFICATION ................................................................. xi 
LIST OF FIGURES AND TABLES ................................................................................................. 3 
LIST OF ABBREVIATIONS ........................................................................................................... 4 
CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW .............................................. 5 
1.1 Stroke ....................................................................................................................................................... 5 
1.2 Cognition and Post-Stroke Cognitive Impairment .................................................................................. 7 
1.3 Post-Stroke Depression ......................................................................................................................... 14 
1.4 Quantitative Electroencephalography (QEEG) and Stroke ................................................................... 16 
1.5 Thesis Outline and Aims ....................................................................................................................... 24 
Study 1 ......................................................................................................................................................... 24 
Study 2 ......................................................................................................................................................... 24 
Study 3 ......................................................................................................................................................... 24 
CHAPTER 2. INVESTIGATING CORRELATIONS BETWEEN FRONTAL QEEG 
INDICES AND POST-STROKE FUNCTIONAL COGNITIVE OUTCOME ......................... 25 
2.1 Foreword................................................................................................................................................ 25 
2.2 Abstract.................................................................................................................................................. 25 
2.3 Introduction ........................................................................................................................................... 27 
2.4 Methods ................................................................................................................................................. 29 
2.5 Results ................................................................................................................................................... 33 
2.6 Discussion.............................................................................................................................................. 37 
2.7 Acknowledgements ............................................................................................................................... 39 
CHAPTER 3. POST-STROKE COGNITIVE IMPAIRMENT: THE ACCURACY OF A 
PRE-DISCHARGE EEG MARKER SCREENING MEASURE ................................................ 40 
3.1 Abstract.................................................................................................................................................. 40 
3.2 Introduction ........................................................................................................................................... 42 
3.3 Methods ................................................................................................................................................. 45 
2 
3.4 Results ................................................................................................................................................... 48 
3.5 Discussion.............................................................................................................................................. 55 
CHAPTER 4.  INVESTIGATING THE RELATIONSHIP BETWEEN QEEG INDICES AND 
POST-STROKE DEPRESSION ..................................................................................................... 61 
4.1 Abstract.................................................................................................................................................. 61 
4.2 Introduction ........................................................................................................................................... 62 
4.3 Methods ................................................................................................................................................. 65 
4.4 Results ................................................................................................................................................... 68 
4.6 Discussion.............................................................................................................................................. 72 
CHAPTER 5. DISCUSSION AND CONCLUSIONS ................................................................... 77 
REFERENCES ................................................................................................................................. 87 
 
3 
LIST OF FIGURES AND TABLES 
 
Chapter 2 Page Number 
Table 1. Patient demographics and stroke details 34 
Table 2. Correlations between pre-discharge QEEG indices and cognitive and 
general outcome assessed by the FIM-FAM 34 
Figure 1. Scatterplots illustrating the correlations between FIM-FAM and frontal 
relative delta power (A), frontal relative alpha power (B) and frontal DAR (C) 35 
Figure 2. Scatterplots illustrating the correlations between FIM-FAM and global 
relative delta power (A), global relative theta power (B), global relative alpha 
power (C) and global relative beta power (D) 
35 
Chapter 3  
Figure 1. Head plot showing regional electrode groupings 46 
Table 1. Patient demographics and stroke details 49 
Figure 2. Interaction plot showing changes in MoCA scores between pre-discharge 
and outcome assessments 50 
Table 2. Significant Spearman correlation coefficients between pre-discharge 
variables and outcome MoCA scores 51 
Figure 3. Scatterplot of the relationship between pre-discharge occipital relative 
theta power and outcome MoCA score 52 
Table 3. Coefficients of the QEEG model predicting post-stroke cognitive 
impairment 53 
Table 4. Coefficients of the MoCA model predicting post-stroke cognitive 
impairment 54 
Figure 4. ROC curve using QEEG predictor variables: occipital and 
centrotemporal theta frequency power 54 
Chapter 4  
Table 1. Patient demographics and stroke details 69 
Figure 1. Scatterplot of GDS score and delta BSI in T5-T6 electrodes 70 
Table 2. Correlation table including Spearman correlation coefficients for all 
significant correlations between GDS scores and pre-discharge and outcome 
variables 
70 
Table 3.Coeficiants of the QEEG model predicting PSD 71 
 
4 
LIST OF ABBREVIATIONS 
ACA: Anterior cerebral artery 
ACIS: Anterior circulation ischaemic strokes 
AD: Alzheimer’s disease/dementia 
ADL: Activities of daily living 
BI: Barthel Index 
BSI: Brain symmetry index 
DAR: Delta:alpha ratio 
DSM-IV: Diagnostic and Statistical Manual – 5th edition 
DTABR: Delta:theta/Alpha:beta ratio 
DWI: Diffusion weighted imaging 
EEG: Electroencephalography 
EMG: Electromyographic 
FIM-FAM: Functional Independence Measure-Functional Assessment Measure 
GDS: Geriatric Depression Scale 
HADS: Hospital Anxiety and Depression Scale 
IS: Ischaemic stroke 
MADRS: Montgomery and Asberg Depression Rating Scale 
MCA: Middle cerebral artery 
MCI: Mild cognitive impairment 
MMSE: Mini Mental State Examination 
MoCA: Montreal Cognitive Assessment 
MRI: Magnetic resonance imaging 
mRS: Modified Rankin Scale 
NCCT: Non-contrast computed tomography 
NIHSS: National Institute of Health Stroke Scale 
PSD: Post-stroke depression 
QEEG: Quantitative electroencephalography 
rCBF: Regional cerebral blood flow 
TCD: Transcranial Doppler Sonography 
TIA: Transient ischaemic attack 
VaD: Vascular dementia 
VCI: Vascular cognitive impairment 
VCIND: Vascular cognitive impairment no dementia 
5 
CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
 
This chapter will begin with a brief introduction on stroke including current treatments and 
therapies employed to treat the condition, 1.1.  I will them move on to discuss and assess current 
literature regarding post-stroke cognitive impairment including commonly used screening tools, 1.2.  
In the following section, 1.3, I will discuss and review literature on post-stroke depression (PSD) 
including screening tools and risk-factors associated with PSD.  In section 1.4 I discuss quantitative 
electroencephalography (QEEG) and how it has been used to assess stroke severity as well as 
measure cognitive impairment and PSD in both stroke and non-stroke samples.  In the final section 
of this chapter, 1.5, I outline the aims and hypotheses of the thesis. 
 
1.1 Stroke 
Types of stroke 
Stroke occurs as a result of an interruption of the blood supply to the brain.  There are two causes of 
stroke, ischaemia and haemorrhage.  Ischaemic strokes are caused by a blockage in the arteries of 
the brain resulting in a restriction of blood to the brain structures (Donnan et al., 2008).  
Haemorrhagic stroke is caused by bleeding in the brain (Donnan et al., 2008).  The majority of 
stroke occurrences are ischaemic, for example in Australia only 1 out of every 5 strokes is caused 
by haemorrhage (Stroke Foundation Australia, 2015). Both types of stroke result in infarction 
caused by neuronal death as a result of the lack of oxygen and nutrients to brain structures (Donnan 
et al., 2008). 
 
The varied impacts of stroke 
Stroke is the second most common cause of death and major disability in the world (Donnan et al., 
2008) and is a problem not only for developed nations, where aging populations increase the 
number of people at risk of stroke, but also in the developing world (Krishnamurthi et al.). Globally, 
over the past two decades (1999-2010) incidence of stroke has significantly increased as have the 
number of associated deaths and disability-adjusted life years (Krishnamurthi et al.). In 2014 there 
were over 51,000 incidences of stroke across Australia (Stroke Foundation Australia, 2014).   
 
Two thirds of stroke survivors will have an impairment that affects their ability to carry out their 
activities of daily living (ADL) following stroke. These events come with a high social and 
financial burden for the individuals, their families and the communities in which they live. 
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Additionally, increased levels of disability and dependence are associated with increasing 
healthcare costs (Fattore et al., 2012).  The financial cost of stroke in Australia, in 2012, was 
estimated to be $5 billion (The Economic impact of stroke in Australia, 2013); expenditure includes 
provision of acute hospital care, rehabilitation, secondary prevention and carer costs. As well, the 
loss of employment as a result of stroke symptoms contributes to personal financial stress for the 
stroke survivor (Flynn et al., 2008).   
 
Perhaps the most concerning contributor to the care, well-being and cost of stroke survivors is 
cognitive impairment. Cognitive impairments are common following stroke, with various studies 
reporting impairments in approximately one-quarter to one-half of patients, at several months post-
stroke (Kelly-Hayes et al., 2003, Srikanth et al., 2003, Douiri et al., 2013).  
 
Acute ischaemic stroke treatment 
In recent years there have been several advances in therapies addressing the acute needs of the 
stroke survivor which have positively impacted ischaemic stroke outcomes.  Manual or drug 
assisted recanalisation of an occluded artery shortly following ischaemic stroke can result in saved 
penumbra and smaller infarctions leading to better outcomes.  A meta-analysis of 9 randomised 
alteplase trials report that 259 of the 787 patients who received this treatment (33%) had a good 
outcome compared to 176 of 762 (23%) who did not receive treatment (Emberson et al., 2014). 
Although recanalisation is effective in a modest but significant proportion of patients there are 
many stroke cases where this therapy is not available or recommended.  This leaves a significant 
number of stroke cases relying only on rehabilitation strategies and the spontaneous, natural 
recovery and repair processes.   
 
Early assessments that screen for, or prognosticate, various post-stroke functional deficits or 
impairments, have also been used to guide clinical decision-making on a range of matters, including 
discharge or rehabilitation strategies and patient management.  Given that post-stroke cognitive 
impairment impacts on patient’s level of independence; are associated with significantly higher care 
costs; heighten the risk of depression, and lower quality of life (Claesson et al., 2005, Cumming et 
al., 2014) the current research focuses on early screening and prognostication of post-stroke 
cognitive impairments and depression (PSD). 
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1.2 Cognition and Post-Stroke Cognitive Impairment 
Terms and criteria used to characterise cognitive impairment 
As noted above, cognitive impairments are common following stroke. Human cognition is 
conceptualised in terms of multiple cognitive “domains” such as memory, visuospatial capacity, 
attention, language and executive function. Executive function typically comprises higher-order 
processes that govern functions in non-routine situations for example when various cognitive and 
behavioural processes such as attention, problem solving and response initiation work in concert 
(Zinn et al., 2007). Any one or combination of these cognitive domains can be impaired following 
stroke, as described in further detail below.  
 
Cognitive impairment following stroke can be characterised and labelled in various ways.  Mild 
cognitive impairment (MCI) for example is generally referred to as the cognitive status between 
normal aging and dementia; it is not specific to patients with vascular disease or stroke 
(Narasimhalu et al., 2009). For instance patients with MCI are able to carry out their ADL however 
they have do have subjective and objective memory deficits. These deficits however are not severe 
enough to fulfil the criteria for Alzheimer’s disease (Petersen et al., 1997). One criticism of using 
MCI criteria to characterise post-stroke cognitive impairments is that it was not designed for 
specific use in stroke patients (Stephan et al., 2015).  In their study that assessed the value of MCI 
diagnosis in stroke patients (Stephan et al., 2015) found that although many patients had cognitive 
impairments most did not fulfil the criteria for MCI.  They found that many stroke patients had 
physical disabilities that prevented them from carrying out their ADL and thus excluded them from 
the MCI criteria. Therefore Stephan et al. suggested a more robust measure of post-stroke cognitive 
impairment such as vascular cognitive impairment no dementia (VCIND) sometimes referred to as 
just vascular cognitive impairment (VCI). VCIND and VCI is a broad classification of cognitive 
impairments specific to stroke patients and those with vascular disease who do not fulfil criteria for 
dementia (Stephan et al., 2009). A shortcoming of VCIND and VCI terms is a lack of official 
classification criteria and the large range in severity of impairments from mild to more severe ‘pre-
dementia’ (Stephan et al., 2015).  
 
Vascular dementia (VaD) characterises a severe cognitive impairment as a result of vascular 
disease.  Again the categorisation encompasses patients with varying degrees of disability and 
severity (albeit on the moderate to severe end of the spectrum).  Along with neurological and 
imaging evidence of vascular disease, diagnosis is made according to Diagnostic Statistic Manual 
IV (DSM-IV) criteria for vascular dementia (Godefroy, 2007).  There are various other acronyms 
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used to describe measures of cognitive impairment that are largely repetitive variations and sub-
groups of those measures described above.  
 
While these classifications go somewhat towards describing cognitive impairments in patients 
following a stroke they do not exclusively describe those patients experiencing post stroke cognitive 
impairment. Throughout this thesis, the term post-stroke cognitive impairment will be used unless 
specified otherwise in the individual research papers. 
 
Screening for post-stroke cognitive impairments 
The Clinical Guidelines for Stroke Management (National Stroke Foundation, 2010) recommend 
that all stroke patients be screened for cognitive impairments and referred for appropriate therapy 
(National Stroke Foundation, 2010). Without formal screening impairments can go unrecognised; 
one study found that stroke patients who underwent a battery of cognitive and functional testing had 
at least one cognitive impairment that was not documented in hospital chart notes (Edwards et al., 
2006).  Although a full neuropsychological work up of a patient is the most comprehensive 
assessment, exhaustive testing is both unfeasible and unreasonable in an acute stroke hospital ward.  
Comprehensive testing in the acute stage is challenging, patients are often in multi-bed rooms, they 
are fatigued or fatigue easily and they often have unstable and fluctuating symptoms and 
impairments.  Patient time is also at a premium in specialised stroke units due to the competition for 
access to the patients by the multidisciplinary team of allied health clinicians. Lengthy and intensive 
assessments are not favoured so short cognitive assessments are a commonly employed alternative. 
Two widely used screening tests relevant to this research are the Mini Mental State Examination 
(MMSE) (Folstein et al., 1975) and the Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 
2005).  The MMSE was originally developed as a short screening test that assesses cognitive 
function in various clinical and community populations including those with personality and 
affective disorders as well as those with dementia (Folstein et al., 1975).  The MMSE comprises 11 
questions that probe orientation, memory and language.  The MoCA is a 30 point test, originally 
developed to detect MCI in community populations (Nasreddine et al., 2005).  The MoCA assesses 
various cognitive domains that may be affected following stroke including executive function, 
attention, memory, visuospatial abilities, language and orientation (Nasreddine et al., 2005).  Both 
tests take approximately 10 minutes to administer and require the patient to have intact visual 
abilities, be able to write and have the ability to express themselves and understand commands, thus 
limiting the number of stroke patients with whom they may be used.  The MoCA is generally able 
to pick up more cognitive impairments than the MMSE and may be considered more sensitive to 
MCI (Pendlebury et al., 2010).  The MMSE does not have items specifically designed to assess 
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attention and executive function and those designed to assess recall and repetition have been judged 
as too simple to detect mild impairments (Pendlebury et al., 2010). 
 
Both the MoCA and MMSE are informative of cognitive impairment at 3 to 6-months post-stroke 
(Arciniegas et al., 2011, Dong et al., 2012). However the degree to which the tests are sensitive 
enough to detect all cases of cognitive impairment and specific enough to rule out those without 
impairment have been debated.  The MoCA has been shown to be more sensitive to milder 
cognitive impairments than the MMSE in acute stroke.  In a sample of 100 stroke patients assessed 
using the MoCA and the MMSE within 14 days of stroke, the MMSE was found to be less sensitive 
than the MoCA in detecting impairment (Dong et al., 2010).  Similar findings were reported in 
assessment of cognitive impairment in sub-acute stroke; in a community sample of 91 stroke and 
TIA patients more than 1-year post stroke the MoCA was found to be more sensitive in detecting 
MCI than the MMSE (Pendlebury et al., 2012b).  Additionally the MoCA has also been shown to 
be a reliable test of VaD above that of the MMSE (Freitas et al., 2012).  Freitas et al. (2012) 
compared groups of patients with VaD, Alzheimer’s dementia (AD) and healthy adult group.  They 
found that the MoCA was able to discriminate between the clinical (AD and VaD) and healthy 
groups significantly and with greater sensitivity and specificity than the MMSE (Freitas et al., 
2012). 
 
Although the MoCA has been proposed as the more sensitive screening measure of post-stroke 
cognitive function (Dong et al., 2010, Pendlebury et al., 2010, Freitas et al., 2012) there are 
limitations on the types of patients who can participate in this type of assessment and also the type 
of patients that were included in the validation studies for these measures (Wall et al., 2015).  Many 
studies using these measures exclude patients with aphasia and those who functionally cannot 
complete the writing or reading tasks, such as those with dominant limb hemiparesis or visual 
disturbance. This results in a testing bias towards sub-groups rather than a representative clinical or 
community stroke sample.  Additionally the tests require capabilities a stroke patient may not have 
following stroke such as full visual and audio fields, no dysphasia and the ability to write. In a 
sample of stroke and TIA patients more than 1 year post-stroke there were 63 out of 413 (15%) who 
were unable to complete a MoCA or MMSE due to stroke related impairments as well as pre-
morbid conditions (Pendlebury et al., 2010). The most common conditions that precluded 
participation were dysphasia (30%), dementia (19%), vision impairments (15%) and difficulties 
with English (10%) (Pendlebury et al., 2010).  Assessment or screening tools without these 
limitations that could be used independently or in conjunction with brief cognitive assessments have 
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not yet been devised but would however be useful in specifically targeting post-stroke cognitive 
impairment. 
 
In recent years significant study and examination has been made with regard to the direction of 
rehabilitation targeting cognitive impairment following stroke (Shigaki et al., 2014, Basford and 
Malec, 2015).  Early and accurate screening of cognitive impairment following stroke is critical for 
engagement in cognitive rehabilitation programs.  The early identification of post-stroke cognitive 
impairments is vital due to the impact such impairments can have on rehabilitation of physical and 
functional deficits.  Successful rehabilitation programs should have the flexibility to accommodate 
common cognitive impairments such as those affecting attention and executive function.  The 
functional independence and functional assessment measure (FIM-FAM) is routinely used in 
rehabilitation centres to assess and monitor the level of independence an individual has in carrying 
out ADL. In addition to several motor tasks such as locomotion and hygiene the FIM-FAM includes 
5 cognitive items.  The measure rates patients in their level of independence in managing memory, 
orientation, attention, problem solving and safety judgement tasks encountered in day to day living.  
The FIM-FAM is assessed by observation and interview of the patient.  A sub-score of cognitive 
items from the FIM assessment have previously been used to assess cognitive outcome in stroke 
patients (Gialanella and Ferlucci, 2010, Gialanella, 2011).  Although the FIM-FAM avoids the 
pitfalls of pen and paper assessment, as detailed previously regarding the MoCA and MMSE, it can 
be a coarse measure.  It may be adequate for a general picture of functional cognitive performance 
in day to day activities however may lack in objective and nuanced assessment of distinct cognitive 
domains.  As above, screening tools without the limitations of the MoCA, MMSE or FIM-FAM 
would be well placed to provide additional information regarding post-stroke cognitive impairment 
in patients who may not otherwise receive formal assessment. 
 
Cognitive domains and post-stroke cognitive impairments 
Cognitive function comprises multiple domains that tend to work in concert rather than independent 
of each other and include memory, visuospatial capacity, attention, language and executive 
function. Each of these domains can be affected by stroke, and being a heterogeneous condition, 
different domains may be affected to varying degrees in individual patients.  Attentional and 
executive functioning impairments are the most common following stroke (Cumming et al., 2013, 
Hurford et al., 2013).  To assess cognitive function following stroke, performance in a 
comprehensive neuropsychological assessment was compared between an age and sex matched 
group of 89 mild to moderate severity ischaemic stroke patients (3-months post-stroke) and 89 non-
stroke participants.  As a group, stroke patients were more impaired than non-stroke participants in 
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attention (15% and 11%), spatial ability (26% and 20%), language (13% and 10%) and executive 
functioning (15% and 9%) tasks (Srikanth et al., 2003).  There was no difference in performance of 
orientation or memory tasks between stroke and non-stroke groups.  An even greater degree of 
impairment was found in a study that assessed cognitive function within a month following stroke 
in 209 patients.  Seventy-two percent of the post-stroke group had attention and speed impairments 
within 1 month of stroke and 38% were still impaired after 3 months post-stroke (Hurford et al., 
2013). Again attention was found to be the most commonly impaired domain followed by executive 
function with 34% of patient’s impaired within 1 month post-stroke.  Both studies assessed 
cognitive function in ischaemic stroke patients and both report a predominant feature of attentional 
and executive function impairment.  Although cognitive impairment tends to be greater within a 
month following stroke, attention and executive function impairments are still very common at 3 
months and onwards.  Effective post-stroke screening methods should probe these commonly 
affected cognitive domains.  
 
Post-stroke cognitive impairment-prevalence and incidence 
Prevalence and incidence statistics vary between studies according to factors such as the different 
stroke sub-types included, the timing of cognitive assessments, the test(s) and scales used and the 
classification or diagnostic criteria employed (Sachdev et al., 2006, Tang et al., 2006, Serrano et al., 
2007, Douiri et al., 2013a).  One of the relatively more modest statistics reported is that 22% of 
1,618 patients suffered substantial cognitive impairments within 3 months post-stroke (Douiri et al., 
2013a). Whereas another study reported that 53% of stroke patients (52 of 99) had some form of 
cognitive impairment at 3-months post-stroke (Srikanth et al., 2003).  Broadly consistent with these 
findings, the Framingham study reported that at 6 months post-stroke 46% of 108 patients had 
cognitive impairments (Kelly-Hayes et al., 2003).While another study of 599 stroke patients found 
that 485 (81%) had a cognitive impairment at an average of 4.5 years post stroke (Qu et al., 2015).  
However, the latter statistic is likely inflated in comparison to the previous two due to an extended 
follow-up time and by 4.5 years post-stroke dementia may not necessarily be due (primarily) to the 
(initial) stroke. In summary it can be said that the prevalence and incidence of cognitive impairment 
following stroke ranges from between 22-81% of post-stroke patients. 
 
Stroke location and cognitive impairment 
Frontal and Temporal Lobe: The location of infarction following stroke can impact the risk of 
developing subsequent cognitive impairment.  Rates of impairment tend to be high in anterior 
circulation stroke (Jaillard et al., 2009, Douiri et al., 2013) likely due to the fact that the frontal 
lobes are known to critically support various cognitive functions (Stuss, 2002).  First ever anterior 
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circulation stroke, in particular ischemic stroke in the middle cerebral artery (MCA) territory, was 
found to be a strong predictor of cognitive impairment within a month of stroke (Jaillard et al., 
2010).  Nys et al. (2005) investigated the associations between lesion location and recovery of 
cognitive function between 3 weeks and 10 months post-stroke in a sample of 111 first time stroke 
patients (Nys et al., 2005).  Frontal lobe stroke occurred in 16% of the sample and was associated 
with poor recovery of reasoning and visuospatial function.  Temporal lobe stroke occurred in 22% 
of the sample and was associated with poor recovery of executive function and verbal memory (Nys 
et al., 2005).  Occipital stroke occurred in 14% of the sample and was associated with poor visual 
perception and visual memory tasks. 
 
Left and Right Hemisphere: In addition to the associations between anterior stroke and cognitive 
impairments, in comparison to lesions in the right hemisphere those in the left are often associated 
with increased cognitive impairments (Jaillard et al., 2010).  Comprehensive neuropsychological 
assessment was carried out in 168 first time stroke patients within 3 weeks of stroke to assess 
abstract reasoning, verbal memory, executive function, visual perception and memory, neglect and 
language (Nys et al., 2007). Those with left hemisphere infarcts were found to have a higher 
prevalence of cognitive impairments than those with right particularly in executive functioning, 
language, verbal memory and abstract reasoning tasks (Nys et al., 2007).  In another study of 62 
ischaemic and haemorrhagic stroke patients those with right hemisphere infarcts performed better in 
cognitive tasks than those with left hemisphere infarcts (Hochstenbach et al., 2003).  There are 
suggestions that the bias seen towards greater impairments in left hemisphere stroke may be due to 
impaired language function and a reliance of language performance in cognitive assessments 
(Cumming et al., 2013). 
 
Cortical and sub-cortical stroke: Stroke affecting cortical regions is often associated with increased 
risk of cognitive impairment as evidenced by several studies (Nys et al., 2005, Nys et al., 2007). 
Cognitive function is dependent upon cortical processing however sub-cortical structures are also 
important for various cognitive processes.  This may explain why there are several studies that 
report no difference in the degree of cognitive impairments or performance between groups with 
cortical and sub-cortical stroke (Hochstenbach et al., 2003, Jaillard et al., 2010).  More than half of 
the patients with lacunar stroke, affecting deep structures such as the thalamus and basal ganglia, 
screened positive for cognitive impairments within the first week of stroke (Fure et al., 2006).  
These most commonly included impairments in executive functioning and memory (Fure et al., 
2006).  It is well established that the thalamus is involved in cognitive processing and damage to the 
area can cause impairments particularly with memory function (Van der Werf et al., 2000).  In 10 
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patients with thalamic lesions following stroke, impairments in attention, memory and executive 
function were documented (Van der Werf et al., 2003).  Infarct in the basal ganglia is often 
associated with motor deficits and movement disorders; however there is evidence that cognitive 
impairment can be affected as a result of basal ganglia lesion.  Cognitive function was compared 
between a small sample of patients with basal ganglia infarct and a community population.  Patients 
with basal ganglia infarct were found to perform significantly worse in tests of memory, attention, 
executive function, visuospatial and language tasks (Hochstenbach et al., 1998).  Although cortical 
lesions are often most commonly associated with cognitive impairments following stroke sub-
cortical lesions can also cause such impairments. 
 
Post-stroke cognitive impairment and dementia 
There is little doubt that stroke increases the risk of developing subsequent dementia; compared to 
stroke free elderly those with stroke have a four-fold increased risk in developing dementia 
(Desmond et al., 2002).  In patients with a moderate post-stroke cognitive impairment there is a six-
fold increase in conversion to dementia (Narasimhalu et al., 2009). Poor performance in brief 
cognitive screening tests is a predictor of subsequent dementia two years following stroke (Stephan 
et al., 2015). Between 20-26% of stroke survivors will develop dementia in the years following 
stroke (Desmond et al., 2002, Pendlebury and Rothwell, 2009, Bejot et al., 2011).  While attentional 
and executive functioning deficits are common following stroke, patients with post-stroke dementia 
in addition tend to have memory, orientation and language deficits (Ballard et al., 2003, Stephens et 
al., 2004, Stephan et al., 2015).  Along with memory impairments increased age and recurrent 
stroke were significant predictors of post-stroke dementia in a sample of 362 stroke patients who 
were followed-up for an average of 3.2 years post-stroke (Narasimhalu et al., 2009). 
 
Risk factors comorbidities and outcomes associated with cognitive impairment  
Factors such as age and various other complications and co-morbidities are associated with 
cognitive impairment following stroke.  Increased age is associated with increased levels of 
cognitive impairment, with the prevalence of cognitive impairment increasing by 2% for each year 
of age following first time stroke, once analyses were adjusted for various confounding variables, 
including stroke sub-type, demographic and pre-stroke risk factors (Douiri et al., 2013).  
 
In addition to age, prevalence of disability was found to be twice as high in patients with cognitive 
impairments as those without cognitive impairment (Douiri et al., 2013).  Cognitive impairment 
following stroke is associated with an increased degree of functional impairments resulting in 
greater levels of dependent living for patients compared to those patients without cognitive 
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impairment (55% vs 33% respectively) (Tatemichi et al., 1994).  Patients with cognitive impairment 
at 1 year post-stroke were found to have a 6-fold increased risk for low-level physical activity 
(Pahlman et al., 2012).  Low-level activity at most indicates only partial completion of ADL and 
light activities.   
 
Unsurprisingly the costs of care in the first year following stroke are three times higher in patients 
with cognitive impairments than those without (Claesson et al., 2005).  In addition to increased 
financial costs associated with post-stroke cognitive impairment quality of life is also negatively 
impacted. The quality of life assessment measures function across 5 domains including, illness, 
independence, social relationships, physical senses (sight, hearing and communication) and 
psychological wellbeing (Cumming et al., 2014). Cognitive impairment, particularly in attentional 
and visuospatial domains is associated with lower quality of life post-stroke (Cumming et al., 
2014).  This association remained even when stroke severity, depression and age was taken into 
account.   
 
1.3 Post-Stroke Depression 
Associations between post-stroke depression and cognitive impairment 
Depression is the most common psychiatric condition following stroke and affects approximately 3 
in 10 patients (Hackett et al., 2005, Ayerbe et al., 2011). Post-stroke depression (PSD) and 
cognitive impairment appear to be associated with each other and the occurrence of either condition 
tends to increase the risk of the other.  A recent systematic review outlines 15 studies that 
investigated the relationship between cognitive impairment and PSD, however, only 6 of the studies 
report a significant relationship between cognitive impairment and PSD (De Ryck et al., 2014a).  
 
Studies that compare levels of cognitive impairment between groups of depressed and non-
depressed stroke patients tend to find significant relationships between PSD and cognitive 
impairment while those that assess the post-stroke population as a whole tend not to find a 
relationship.  Kauhanen et al. (1999) grouped 106 first ever ischaemic stroke patients as depressive 
and non-depressive (using DSM-III criteria) and assessed cognitive impairments using a 
neuropsychological test battery at 3 and 12-months post-stroke. Depressive patients performed 
consistently worse across attention, executive function, memory, problem solving and visuospatial 
tasks than non-depressed patients (Kauhanen et al., 1999).  These results were replicated in a 
sample of 201 stroke patients, who were assessed using the Cornell Scale for Depression (CSD) and 
the Montgomery and Asberg Depression Rating Scale (MADRS) instead of the DSM criteria (De 
Ryck et al., 2014c).  Those with PSD tended to perform worse on the MMSE and the Functional 
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Independence Measure (cognitive sub-scale) assessed at 1, 3, 6, 12 and 18 months post-stroke the 
than those without depressive symptoms (De Ryck et al., 2014b).  Similarly in 420 ischaemic stroke 
patients, those with PSD, classified using the Hospital Anxiety and Depression Scale (HADS), 
performed significantly worse on the MMSE than those without PSD (Snaphaan et al., 2009).  
Lastly this relationship was replicated in 84 patients with lacunar stroke and PSD assessed using the 
Geriatric Depression Scale (GDS), MMSE scores in the PSD group were significantly lower than 
the 154 patients without PSD (Tang et al., 2011).  
 
It is important to note that although evidence does suggest that a significant relationship between 
PSD and cognitive impairment exists, it is not seen in all studies. Several investigations have found 
no difference in the cognitive performance between depressed and non-depressed stroke patients 
(Burvill et al., 1997, Pohjasvaara et al., 1998, Brodaty et al., 2007). 
 
PSD and functional impairment 
In addition to the potential association with cognitive impairments, PSD is associated with 
increased functional disability following stroke (Burvill et al., 1997, Pohjasvaara et al., 1998, 
Kauhanen et al., 1999, Brodaty et al., 2007, Berg et al., 2009, De Ryck et al., 2014b).  In a 
community based population of stroke patients a significantly greater number of patients with 
functional impairments had depression (assessed using the Hamilton Depression Rating Scale) and 
patients with depressed mood following stroke were more likely to have severe disability at 6-24 
months post stroke (Willey et al., 2010).  First ever ischaemic stroke patients with PSD, diagnosed 
using DSM-III criteria, were more likely to be disabled and more dependent in carrying out their 
ADL’s than those without depression at 4 and 12 months post-stroke (Kauhanen et al., 1999).  In a 
recent study outlined above PSD was only significantly associated with functional impairments and 
disability at 3 months post stroke, this relationship was not significant 6, 12 or 18 months post 
stroke (De Ryck et al., 2014b).  These findings may suggest that the relationship between PSD and 
functional impairment peaks at 3 months post-stroke and tapers off at 12 months post-stroke.   
 
Past research tends to indicate a significant relationship between PSD and both functional and 
cognitive impairments.  Although at this point the direct cause of the relationships is yet to be 
elucidated it is important to identify and address PSD in the early stages following stroke. Effective 
treatment following identification of the condition may reduce the impact of depression on 
functional and cognitive impairment. 
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Screening for PSD 
Although post-stroke depression is common and associated with functional outcomes and cognitive 
impairment it is largely unexplored and underdiagnosed in acute stroke hospital units.  A 
comprehensive assessment based on DSM-V criteria by a registered mental health professional is 
the gold standard for identifying and diagnosing post-stroke depression.  However, it is unrealistic 
and unnecessary to have a mental health professional conduct interviews and assessments with all 
stroke patients at an acute stage.  There are several commonly used screening tests to detect PSD 
both in acute and later stages of stroke.  These tests can be carried out by trained health 
professionals such as nurses, occupational therapists or social workers and flagged for further 
investigation with patients identified as being at risk of PSD. 
 
The Geriatric Depression Scale (GDS) was developed as a yes/no format depression assessment 
without any somatic items (Yesavage et al., 1982).  This means that the assessment can be used in 
patients with functional impairments as a result of a medical condition other than depression, such 
as those found in stroke patients. There is a validated short version of the test with just 15 items 
which addresses concerns over the impact of post-stroke fatigue and duration of the assessment 
(Javaid I. Sheikh, 1986). The GDS is sensitive to the characteristics of depression in elderly 
populations however, it is not specific to those with stroke.  There are obvious concerns when using 
such scales is whether they are sensitive to the condition of the stroke population.  Wording of items 
such as over the past week, ‘Have you dropped off many of your activities and interests?’ may not 
be appropriate in patients with stroke related functional impairment and disability or those who are 
in in-patient hospital or rehab units.  Informative screening measures would be able to indicate 
persistent degree of depression despite possible cognitive or functional impairments preventing full 
participation in standard pen and paper and interview based screening measures.  For example, a 
patient with cognitive impairments may have a lack of understanding and insight that prevents 
reliable testing.  Improved screening methods that avoid these deficits would help identify patients 
eligible for treatment and have the ability to lead to better rehabilitation participation and outcomes 
including returning to work and/or daily tasks. It is suggested in this research that 
Electroencephalography (EEG) could be a useful screening method leading to better rehabilitation 
participation and outcomes for stroke survivors. 
 
1.4 Quantitative Electroencephalography (QEEG) and Stroke 
EEG methodology 
EEG is an established method of monitoring and recording brain function using electrodes placed 
on the scalp to detect the brains electrical activity (Niedermeyer and Da Silva, 2005).  EEG is a 
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non-invasive technique with minimal disturbance to the patients.  Recordings can be done with eyes 
closed or open, however eyes closed is often preferred to minimise electromyographic (EMG) 
artifact from eye movements and blinking. There is little constraint on the conditions under which 
EEG can be recorded and it is used routinely in clinical settings.  EEG recorders are relatively 
portable and are often used at the bedside.  Recordings do not need to be prolonged and usually just 
several minutes of clean EEG are needed for analysis.   
 
Computerised spectral analysis of EEG recordings, referred to as quantitative EEG (QEEG), was 
developed with diagnostic values in mind (Niedermeyer and Da Silva, 2005).  QEEG measures the 
signal intensity or power (with units microvolts squared) of EEG activity in a specified frequency 
range. Frequencies between 0-30Hz are of physiologic interest and are separated into 4 individual 
bands: faster beta (13-30 Hz) and alpha (8-12Hz); and slower theta (4-7 Hz) and delta (1-3 Hz) 
frequencies (Niedermeyer and Da Silva, 2005).  In addition to measuring power values of individual 
frequency bands, ratios of slow to fast activity, such as the delta:alpha ratio (DAR) and delta-
theta:alpha-beta ratio (DTABR) are commonly employed (Finnigan and van Putten, 2013).  The 
brain symmetry index (BSI) is another frequently used tool to assess the degree of asymmetry 
between the left and right hemispheres of the brain (Finnigan and van Putten, 2013). 
 
Due to the difficulty in using pen and paper tests in acute stroke, and the importance of early 
identification of PSD and cognitive impairment, the use of readily obtainable, non-invasive QEEG 
measures would be well suited.  Although there are limited studies that directly document the 
relationship between acute/pre-discharge QEEG measures with both cognitive impairment and PSD 
there are related studies that indicate possible associations and allow us to develop hypotheses.  In 
non-stroke populations there is evidence that EEG/QEEG can be used to reveal cognitive 
performance and moreover indicate cognitive impairment (Cummins et al., 2008, Jackson and 
Snyder, 2008). QEEG indices have been shown to predict subsequent cognitive decline e.g. 
progression to dementia in mild cognitive impairment (Jelic et al., 2000, Moretti et al., 2011).  In 
addition QEEG indices have been linked to cognitive performance in older healthy adults and in 
those with mild cognitive impairment (Cummins et al., 2008).  Although not as comprehensively 
studied PSD has been associated with several resting state QEEG indices (Zhang et al., 2015).  In 
non-stroke populations distinct EEG patterns have been found when depressed participants have 
been compared to healthy controls (Grin-Yatsenko et al., 2009).  
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EEG abnormalities and post-stroke cognitive impairment 
The underlying neurophysiology of cognitive impairment following stroke has not been 
comprehensively studied (particularly in ‘acute’ stroke patients).  However, patients with EEG 
abnormalities are more likely to develop cognitive impairment within two years of stroke (Gur et 
al., 1994). In their study EEG’s recorded within 48 hours of stroke were classified as normal or 
abnormal (focal or diffuse slowing).  Patients with abnormal EEG were found to have a 2.6 times 
greater risk of developing dementia within a two year follow up period than those with a normal 
EEG recording (Gur et al., 1994). A further study by Elwan et al. (1994) found that when cognitive 
function and EEG recordings were assessed in 57 patients with a history of ischaemic stroke (n=51) 
and TIA (n=6) that EEG abnormalities were associated with greater levels of cognitive impairment 
(Elwan et al., 1994).  Although these studies did not analyse specific QEEG indices the results 
suggest that early/pre-discharge EEG may be indicative of cognitive impairment following stroke.   
 
QEEG synchronicity and cognitive impairment 
Infarct resulting from stroke changes the way affected and unaffected regions of brain communicate 
resulting in abnormal QEEG signals. At 3-months post stroke, in 20 anterior territory ischaemic 
stroke patients alpha frequency synchronicity between lesion affected and unaffected regions of the 
brain was reduced compared to 19 matched healthy controls (Dubovik et al., 2013).  In addition, the 
degree of reduction in alpha synchronicity in stroke patients shared a linear relationship with both 
cognitive and motor deficits (Dubovik et al., 2013).  The relationship was only significant in regions 
involved in the function being tested, for example between verbal fluency performance and the left 
inferior frontal gyrus (Broca’s area).  Lou et al. (2011) investigated active state EEG 
synchronisation in 12 patients with VaD and history of stroke and 12 age-matched healthy 
participants.  Thirty-two channel active state EEG’s were recorded during a classical visual oddball 
paradigm task requiring attention and executive function. The MMSE was used to measure 
cognitive impairment. Patients with VaD had significantly lower levels of synchronisation in the 
delta and theta frequencies than a healthy age matched group (Lou et al., 2011). In addition the 
MMSE scores of all participants were significantly correlated with measures of delta 
synchronisation, and that greater synchronisation was associated with higher MMSE scores (Lou et 
al., 2011).  These studies suggest that desynchronization in delta and alpha frequencies is associated 
with cognitive impairment following stroke and that more generally, delta and alpha frequencies, 
may be of interest when investigating post-stroke cognitive impairment.  
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QEEG slowing and cognitive impairment 
Ischaemic stroke (IS) results in the attenuation of relatively faster EEG activity such as alpha, and 
the emergence of abnormal, slow delta activity particularly at electrodes overlying ischaemic 
regions (Niedermeyer and Da Silva, 2005, Finnigan et al., 2007, Finnigan and van Putten, 2013). 
Szirmai et al. (2005) used transcranial doppler sonography (TCD) and EEG to show a relationship 
between neuronal activity and blood flow during cognitive tasks in a healthy population (Szirmai et 
al., 2005).  It has been suggested that delta activity is associated with regional cerebral blood flow 
(rCBF) while preserved alpha activity is linked to neuronal function (Luu et al., 2001, Niedermeyer 
and Da Silva, 2005, Finnigan and van Putten, 2013a).  Various reports indicate that measures of 
delta power relative to that of faster activity can uniquely inform IS management (Finnigan and van 
Putten, 2013a) and as such slow wave and fast wave indices are often analysed as power ratios 
(either DAR or DTABR) (Claassen et al., 2004).  During acute stages of stroke such ratios are 
uniquely sensitive to even subtle ischaemic changes in brain function (Jordan, 2004) 
 
EEG was recorded in 35 people with a history of sub-cortical VCIND and 22 people with MCI 
living in the community (Sheorajpanday et al., 2014).  Cognitive function was assessed using the 
MMSE and a neuropsychological test battery including assessments of memory, executive function 
and language.  Patients with sub-cortical VCIND had a significantly higher ratio of slow to fast 
activity as measured by the DTABR than the MCI group (Sheorajpanday et al., 2014).  Similar 
results were found in another group of 31 patients with sub-cortical VCIND (Gawel et al., 2009).  
There were significant correlations between MMSE scores and measures of slow relative to fast 
activity, lower MMSE scores, indicating worse cognitive function, were associated with greater 
degree of slow activity (Gawel et al., 2009). 
 
EEG slowing is also linked to cognitive performance in patients with Parkinson’s disease.  A full 
neuropsychological battery including tests of attention, executive function, memory, language and 
visuospatial function and a resting state EEG were recorded in 48 Parkinson’s patients 
(Zimmermann et al., 2015).  They found a significant association between EEG slowing with 
performance of attention, executive function, verbal fluency and long-term memory tasks 
(Zimmermann et al., 2015). Similar results were found in another Parkinson’s population 
(Bousleiman et al., 2014).  Fifty-three patients underwent neuropsychological testing and resting 
state EEG.  They found that regional decreases in alpha power were linked to poorer cognitive 
function (Bousleiman et al., 2014).  Although these results were found in Parkinson’s disease 
populations they support the use of QEEG indices as a measure of cognitive impairment in samples 
with neurological disease/disorders, such as stroke, in particular the investigation of EEG slowing. 
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Increased delta frequency power and decreased alpha frequency power following stroke are also 
associated with both functional and neurological outcomes (Finnigan et al., 2007, Sheorajpanday et 
al., 2011). DAR (recorded at 48 hrs. post-stroke) was significantly positively correlated with 
neurological outcome (assessed by the National Institute of Health Stroke Scale (NIHSS)) at 30 
days post-stroke in 13 ischaemic stroke patients (Finnigan et al., 2007). In a large IS sample 
DTABR collected at 24 hours post stroke was significantly positively correlated with disability 
(assessed by the modified Rankin Scale (mRS)) at 6 months post-stroke. This relationship was still 
found to be significant when controlling for stroke severity as measured by NIHSS and infarct 
volume (Sheorajpanday et al., 2011).  This indicates that acute QEEG frequency ratios that index 
QEEG slowing give unique information about neurological outcome post-stroke and further 
evidence why used in conjunction with brief screening tests may be useful in predicting cognitive 
outcome. 
 
QEEG theta power and cognitive impairment 
Theta frequency power following stroke may also index alpha slowing and cognitive impairment.  
In a group of 105 stroke patients resting state EEG was recorded across 16 channels (Song et al., 
2014).  Patients with greater theta frequency power performed significantly worse on the MoCA 
(Song et al., 2014).  Although these results are significant there were omissions in the methodology 
of the study that must be taken into consideration when interpreting the results, such as: the type of 
stroke patients included in the sample, when the EEG was recorded post-stroke and the stroke 
severity.  Studies of non-stroke populations have documented links between cognitive function and 
theta power (Prichep et al., 1994, Klimesch, 1999, Jackson and Snyder, 2008); as such acute post-
stroke theta power may share an interesting relationship with cognitive outcome. In 73 healthy older 
adults, high relative theta power correlated significantly with better cognitive performance 
including memory and attention tasks (Finnigan and Robertson, 2011). In addition, lower task-
related theta power was observed in 12 MCI patients compared to healthy matched controls during 
recognition tasks (Cummins et al., 2008).  
 
Although there are some reports of significant relationships between post-stroke theta frequency 
activity and stroke severity, Nuwer et al (1987) report that theta frequency power alone, is an 
unreliable index of pathophysiology following stroke (Nuwer et al., 1987). Similarly, Finnigan et al. 
(2007) report no significant correlations between theta frequency power recorded at approximately 
48-hours post-stroke and 30 day NIHSS score (Finnigan et al., 2007). However, in 28 MCA 
territory stroke patients assessed within 72 hours of admission, theta frequency was found to be a 
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better predictor of short term (discharge 6-15 days post stroke) disability (mRS score)  than long 
term outcome (3 months post stroke) (Cuspineda et al., 2007). Measures of theta frequency power 
may more accurately index pathophysiology present at the time of recording rather than 
prognosticate subsequent impairment. 
 
The relationship between post-stroke theta frequency power cognitive impairment is certainly of 
interest.  As discussed above, the results of studies assessing the relationship between theta 
frequency power and general stroke outcome, such as disability, are mixed there are strong 
indications that theta power may index cognitive function, at least, in non-stroke populations. 
 
Brain symmetry index (BSI) and post-stroke outcome 
Ischaemic MCA territory stroke generally affects one hemisphere predominantly; assessment of 
BSI in stroke patients may provide insight into cognitive deficits.  At present there have been no 
studies that investigate the relationship between increased asymmetry in acute stroke patients and 
cognitive impairment. However, in a non-stroke population, resting state EEG was recorded of 35 
participants with sub-cortical VCIND and 22 participants with MCI (Sheorajpanday et al., 2014). 
There was a significant difference in BSI between the VCIND and MCI groups with greater 
asymmetry seen in the VCIND group. Increased asymmetry in VCIND patients was also 
significantly correlated with poorer performance on tests of verbal, global and working memory 
(Sheorajpanday et al., 2014).  BSI has also been linked to cognitive performance in healthy 
(Hoptman and Davidson, 1998).  Resting state EEG was recorded a week following 
neuropsychological testing in a group of 32 healthy participants.  Resting state alpha asymmetry 
was associated with performance on verbal memory and visuospatial and working memory tasks, 
increased activation of central left-hemisphere alpha activity was associated with better 
performance on the former and   increased activation of temporal right hemisphere activity was 
associated with the latter (Hoptman and Davidson, 1998).  These studies suggest a link between 
measures of interhemispheric asymmetry and cognitive impairment in non-stroke populations. 
 
Measures of left and right hemisphere symmetry have also been informative in past stroke studies 
(van Putten and Tavy, 2004).  In a sample of 21 patients with MCA stroke, increased 
interhemispheric asymmetry (higher BSI) was found to correlate strongly with higher NIHSS 
scores, indicating greater stroke symptoms (van Putten and Tavy, 2004).  Similar results were 
reported in a group of 31 ischaemic stroke patients. Increased BSI, recorded within 72 hours of 
stroke, was associated with greater NIHSS scores on hospital admission and an increased diffusion 
weighted imaging (DWI) volume (mL) (Sheorajpanday et al., 2009). Measures of interhemispheric 
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brain asymmetry may be of interest when assessing post-stroke cognitive impairment and 
depression (see below for discussion).  
 
From a review of the literature we can surmise that QEEG indices are linked to general post-stroke 
outcomes such as disability as well as being linked to cognitive function and performance in non-
stroke samples.  The above studies support the hypotheses of the current study that QEEG indices 
may be informative of post-stroke cognitive function. 
 
PSD and QEEG measures 
A recent study investigated the relationship between PSD and QEEG indices.  EEG was recorded in 
43 patients within a year of stroke, of those 21 had PSD diagnosed using DSM-IV criteria (Zhang et 
al., 2015).  Patients with PSD were found to have significantly greater delta power in frontal and 
central electrodes, as well as greater theta power across the entire scalp than patients without PSD.  
Patients with PSD also had significantly greater levels of alpha power in frontal and right temporal 
regions than those without PSD (Zhang et al., 2015).  These findings suggest that PSD results in 
increased power across both slow delta and theta frequencies and fast alpha activity.  These results 
were replicated to some degree in 111 non-stroke patients with early symptoms of depression (Grin-
Yatsenko et al., 2009).  When compared to EEG recordings of 523 healthy control participants, 
those with depressive symptoms had increases in alpha and theta power averaged over 19 
electrodes, delta power was not assessed in this study (Grin-Yatsenko et al., 2009).  A relationship 
between QEEG delta frequency power and depression has been shown in a non-stroke population of 
104 participants (76 participants were classified as depressed based on DSM-IV criteria and 28 
healthy controls) (Morgan et al., 2005).  A significant increase in slow delta frequency power across 
the scalp was observed in depressed versus non-depressed subjects.  However, the study also 
analysed other factors that may affect QEEG indices and found that although there was an increase 
in delta power in depressed patients the increase in delta was greater in patients with impairments 
such as dementia (Morgan et al., 2005).  These findings suggest that although delta frequency 
power may be associated with depression, it is also influenced by other neurological conditions 
such as dementia.  This may also be the case in stroke patients with depression as delta frequency 
power is affected by stroke severity (Finnigan and van Putten, 2013a). 
 
Depression and alpha asymmetry 
There have been several investigations of the association between depression and alpha asymmetry 
in anterior and parietotemporal regions in non-stroke populations (Debener et al., 2000, Blackhart et 
al., 2006, Grin-Yatsenko et al., 2009, Stewart et al., 2011).  It is assumed that depression is 
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characterised by increased activity in the right hemisphere and decreased activity in the left leading 
to lower alpha power in the right and higher alpha power in the left (Olbrich and Arns, 2013).  
However, overall, past research does not indicate that a significant relationship exists between 
depression and alpha asymmetry.  Frontal alpha asymmetry was not significantly associated with 
depressive symptoms in 79 adults with DSM-IV diagnosed (Gold et al., 2013).  A mild but non-
significant positive correlation was found between frontal alpha asymmetry in F7-F8 
interhemispheric electrode pairs and depressive symptoms measured using the Montgomery and 
Asberg Depression Rating Scale (MADRS) (Gold et al., 2013).  Similar results were found in a 
small sample of older participants (>65 years old) including depressed (n=12), remitted (n=8) and 
control subjects. There was no significant difference in interhemispheric alpha asymmetry between 
the three groups (Carvalho et al., 2011).  In a similar protocol another older group (>60 years) 
including both depressed (n=22) and non-depressed (n=14) participants received a resting state 
EEG recording.  Although depressed participants had greater right frontal and left parietal activity 
than non-depressed participants this finding was not significant (Deslandes et al., 2008).  Decreased 
alpha activity in the right hemisphere may be associated with depression, however, findings have 
been inconsistent possibly due to the fact that gender, other mood disorders such as anxiety and age 
and handedness may impact alpha activity in these regions also (Morgan et al., 2005, Stewart et al., 
2011).  This suggests that alpha asymmetry may not be an acceptable diagnostic or screening 
measure to investigate PSD. 
 
Although not as comprehensive as the literature of QEEG and cognitive impairment, studies from 
non-stroke populations suggest that QEEG indices may be indicative of PSD.  The above studies 
support the hypotheses of the current study that QEEG indices may be informative of PSD. 
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1.5 Thesis Outline and Aims 
As outlined above, QEEG indices are informative of general post-stroke outcomes such as 
functional impairments.  In addition, they are related to cognitive function and impairments in non-
stroke populations.  Finally QEEG indices also appear to be associated with depression in non-
stroke populations.  Post-stroke cognitive impairment and depression are prevalent following stroke 
and current screening measures are not optimal for assessing these conditions due to common post-
stroke conditions.  The aim of this research was to investigate the relationship between early pre-
discharge QEEG indices following stroke and subsequent cognitive impairment and depression.  In 
addition the value of such measures in prognosticating and screening for post-stroke cognitive 
impairment and depression was assessed.  The results of the research described in this thesis have 
the potential to contribute novel and clinically relevant findings about the utility of pre-discharge 
QEEG measures to improve early screening of these conditions. 
 
Study 1 
This preliminary study investigated the relationships between pre-discharge QEEG indices and 
cognitive outcomes at 3-months post-stroke.  Correlations between pre-discharge QEEG indices and 
measures of general and cognitive impairment assessed by the Functional Independence Measure 
Functional Assessment Measure (FIMFAM) at 3 months post-stroke were assessed.  Furthermore 
these relationships were compared between QEEG indices calculated from smaller regional groups 
of frontal and posterior electrodes were compared to those calculated from the standard global 19 
electrodes across the entire scalp. 
 
Study 2 
This study investigated the value of pre-discharge QEEG indices in screening for post-stroke 
cognitive impairment at 3-months post-stroke, assessed using the Montreal Cognitive Assessment 
(MoCA).  Logistic regression modelling was used to assess which QEEG indices best predict 
subsequent cognitive impairment.  In addition the optimal cut-off values to classify patients as 
cognitively impaired were identified for the QEEG indices included in the model. 
 
Study 3 
This study investigated the relationship between pre-discharge QEEG indices and subsequent 
depression assessed at 3-months post-stroke using the Geriatric Depression Scale (GDS).  In 
addition the value of QEEG indices in screening for PSD were also assessed using logistic 
regression modelling. 
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CHAPTER 2 
INVESTIGATING CORRELATIONS BETWEEN FRONTAL QEEG INDICES AND POST-
STROKE FUNCTIONAL COGNITIVE OUTCOME 
 
2.1 Foreword 
As outlined in the introduction links between post stroke QEEG indices and stroke severity, 
functional outcome or disability are well documented in the literature.  Historically, what are less 
represented are established links between QEEG indices and cognitive deficits following stroke.  
This chapter comprises the published preliminary study that investigates the relationship between 
QEEG indices and cognitive deficits. The manuscript that follows has minor formatting changes 
from the original version titled ‘Frontal EEG delta/alpha ration and screening for post-stroke 
cognitive deficits: The power of four electrodes’ published in the International Journal of 
Pyschophysiology in 2014.  The reference and link for the manuscript are: 
 
Schleiger E., Sheikh N., Rowland T., Wong A., Read S. and Finnigan S. Frontal EEG 
delta/alpha ratio and screening for post-stroke cognitive deficits: The power of four 
electrodes. International Journal of Psychophysiology. 2014; 94(1): 19-24. doi: 
10.1016/j.ijpsycho.2014.06.012 
http://www.sciencedirect.com/science/article/pii/S0167876014001494 
 
2.2 Abstract 
This study analysed correlations between post-stroke, quantitative electroencephalographic (QEEG) 
indices, and cognition-specific, functional outcome measures. Results were compared between 
QEEG indices calculated from the standard 19 versus 4 frontal (or 4 posterior) electrodes to assess 
the feasibility and efficacy of employing a reduced electrode montage. Resting-state EEG was 
recorded at the bedside within 62–101h after onset of symptoms of middle cerebral artery, 
ischaemic stroke (confirmed radiologically). Relative power for delta, theta, alpha and beta, 
delta/alpha ratio (DAR) and pairwise-derived brain symmetry index (pdBSI) were averaged; over 
all electrodes (global), over F3, F4, F7, F8 (frontal) and P3, P4, T5, T6 (posterior). The functional 
independence measure and functional assessment measure (FIM–FAM) was administered at mean 
105 days post-stroke. Total (30 items) and cognition-specific (5 items) FIM–FAM scores were 
correlated with QEEG indices using Spearman's coefficient, with a Bonferroni correction. Twenty-
five patients were recruited, 4 died within 3months and 1 was lost to follow-up. Hence 20 cases (10 
female; 9 left hemisphere; mean age 68years, range 38–84) were analysed. Two QEEG indices 
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demonstrated highly-significant correlations with cognitive outcomes: frontal DAR (ρ=−0.664, 
p≤0.001) and global, relative alpha power (ρ=0.67, p≤0.001). After correction there were no other 
significant correlations. Alpha activity – particularly frontally – may index post-stroke attentional 
capacity, which appears to be a key determinant of functional and cognitive outcomes. Likewise 
frontal delta pathophysiology influences such outcomes. Pending further studies, DAR from 4 
frontal electrodes may inform early screening for post-MCA stroke cognitive deficits, and thereby, 
clinical decisions. 
 
27 
2.3 Introduction 
Cognitive impairment and vascular dementia are common sequelae of stroke. Prevalence and 
incidence statistics vary between studies but even conservative estimates suggest that more than 
20% of patients exhibit substantial cognitive impairments within 3 months of stroke (Douiri et al., 
2013). The costs of stroke care in patients with cognitive impairments are three times higher than 
those without (Claesson et al., 2005). In addition post-stroke cognitive impairment is a risk factor 
for depression (Nys et al., 2006) and poor functional recovery (Pahlman et al., 2012). The Clinical 
Guidelines for Stroke Management of the National Stroke Foundation of Australia recommend that 
all stroke patients be screened for cognitive deficits and referred for appropriate therapy (National 
Stroke Foundation, 2010). 
 
Brief cognitive screening tools such as the MoCA (Montreal Cognitive Assessment) (Nasreddine et 
al., 2005, Freitas et al., 2012) and MMSE (Mini Mental State Examination) (Folstein et al., 1975) 
administered pre-discharge have been shown to be somewhat informative for predicting cognitive 
impairment at three to six months post-stroke (Dong et al., 2012). However the latter study only 
employed a dichotomous outcome variable: no-mild impairment or moderate to severe impairment. 
Others report that brief screening tests (such as MoCA or MMSE) alone can have limited efficacy 
for predicting cognitive impairment in stroke patients (Srikanth et al., 2006). In addition, 
completion of these requires alertness, unimpaired language function, usage of the dominant hand 
and arm, and functional eyesight and hearing; yet one or more of these are often compromised in 
stroke patients. Potential subjectivity or inter-assessor reliability issues also should be considered. 
Hence there remains a need for a more reliable, objective and robust methodology for early 
screening of post-stroke cognitive impairment. Additionally an ideal method would be available for 
use on all stroke patients without being limited by functionality as brief cognitive assessments are. 
This could help realise more informed and effective clinical management decisions regarding, for 
example, the required level of care, rehabilitation strategies, or patients' capacity to return to work. 
 
In the current study we investigated the potential of quantitative electroencephalography (QEEG) in 
this setting. QEEG produces objective indices of brain dysfunction which have proven useful in 
various clinical applications. The clinical value of QEEG in assessment of ischaemic stroke was 
first reported some decades ago (Pfurtscheller, 1984). Further a recent review focusing on studies 
over the past decade highlights that two classes of global QEEG indices can uniquely inform 
clinical stroke management including prognostication of neurological and general functional 
outcomes (Finnigan and van Putten, 2013). These are: (1) frequency-specific power measures, 
particularly of slow relative to faster band-power, such as the delta/alpha ratio (DAR), or; (2) 
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measures of interhemispheric power (a)symmetry, such as the pairwise derived brain symmetry 
index (pdBSI). In addition numerous outcomes indicate that QEEG indices are sensitive to 
cognitive (Mitchell et al., 2008, Finnigan and Robertson, 2011, Klimesch, 2012) and to (future) 
mild cognitive impairment or dementia, not necessarily resulting from cerebral ischaemia 
(Cummins et al., 2008, Jackson and Snyder, 2008). Hence QEEG may well prove valuable for 
screening of post-stroke cognitive deficits, yet such studies have not been reported to date. 
 
As discussed in a recent review (Finnigan and van Putten, 2013), access to EEG hardware and 
expertise can be a potential challenge and relatedly, so can the total time required for EEG set-up 
and recording. Adoption of a “lower-density” EEG electrode montage could help overcome such 
issues and indeed DAR measures averaged from just four frontal electrodes (F3, F7, F4, F8) were 
significantly correlated with neurological outcomes in a small sample of anterior circulation stroke 
patients (Finnigan and van Putten, 2013). This is an interesting finding, as a four-electrode EEG 
montage is substantially more feasible to acquire than one comprising nineteen (or more) 
electrodes. In addition frontal lobe function is particularly critical to numerous aspects of cognitive 
function, such as attention (Stuss, 2002), and frontal QEEG band-power has been found to correlate 
with measures of cognitive function in healthy older adults (Finnigan and Robertson, 2011). Given 
these various findings we analysed correlations between frontal (as well as global and posterior) 
QEEG indices, with cognitive (and general functional) outcome measures. On the basis of the 
information reviewed above, including the sensitivity of delta to post-stroke pathophysiology and of 
alpha to cognitive function, we hypothesised that QEEG indices sensitive to delta and/or alpha 
power would correlate with post-stroke outcome measures. Furthermore given the previously-
reported links between frontal delta or DAR and outcomes (after middle cerebral artery stroke), as 
well as between alpha activity with frontal lobe function and cognition, we hypothesised that this 
correlation would hold in the case of frontal delta and/or alpha power. 
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2.4 Methods 
Patients 
Approval to carry out the study was obtained from the local University and Hospital Human 
Research Ethics Committees. Written informed consent from each patient or substitute decision 
maker was obtained. Patients with acute neurologic symptoms consistent with anterior circulation 
stroke were initially considered. Patients under 18 years old, pregnant or with previous craniotomy 
were excluded from the study. All patients underwent acute, non-contrast computed tomography 
(NCCT) scanning and the majority of cases also had CT perfusion (CTP) and angiogram (CTA). 
Ischaemic stroke and arterial territory affected by the same was confirmed via acute CT and, in six 
cases, also follow-up magnetic resonance imaging (MRI) including diffusion-weighted imaging 
(DWI). Only patients with middle cerebral artery (MCA) ischaemic stroke thus confirmed were 
included. Time of stroke onset was defined at the time that the patient was last seen without stroke 
symptoms. 
 
EEG data acquisition and initial assessment 
EEG was recorded continuously at the bedside in the acute stroke unit at approximately 72 h post 
stroke symptom onset. In (five) “wake-up” stroke cases, time of stroke onset was defined as the 
mid-point between time to bed (without symptoms) and time of wake-up (with symptoms). A 
NicOne Brain Monitor system (Natus Medical Inc.) was used with a sampling rate of 500 Hz. 
Nineteen Ag/Ag–Cl electrodes (Nicolet) were applied according to the International 10–20 system. 
In addition a reference electrode was positioned midway between Fz and Cz, and a ground electrode 
positioned on collar bone. Electrode impedances were predominantly 5–10 kΩ or less. EEG was 
recorded for approximately 20 min total in resting, awake state with eyes closed. Alertness or 
sleepiness was assessed throughout each recording, primarily via periodic behavioural assessments. 
Within 30 min of the EEG recording the National Institute of Health Stroke Scale (NIHSS) was 
administered. 
 
EEG data analysis 
EEG signal processing and analyses were performed offline using methods that we have previously 
reported (Finnigan et al., 2007, Finnigan and Robertson, 2011, Sheikh et al., 2013). These were 
computed using EEGLAB, Edit 4.5 (Compumedics-Neuroscan) and in-house software, 
respectively. EEG data were filtered (lowpass; 35 Hz, 12 dB/octave) and re-referenced to the 
common average reference. Each continuous data file was segmented into contiguous epochs each 
of 4096ms duration (2048 data points), epochs were baseline-corrected and epochs in which EEG 
amplitude exceeded ± 100μV were automatically rejected. Following this, the data were examined 
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visually and, when appropriate, any remaining epochs containing clear, lower-amplitude artefacts 
(such as arising from blinks or patient movement) were rejected and excluded from further 
analyses. 
 
From the first remaining 45 epochs (184 s) of artefact-free EEG data per participant a Fast Fourier 
Transform (FFT) was applied. This process resulted in a power value for each 0.488 Hz iteration, at 
each electrode. From the resulting power spectra, absolute power was summed across the delta 
(0.98–3.91 Hz), theta (4.39–7.32 Hz), alpha (7.81–12.21 Hz), and beta (12.70–29.79 Hz) bands 
(inclusive). These are minor variations from clinical values; 1–4 Hz, 4–7.5 Hz, 7.5–12.5 Hz and 
12.5–30 Hz, respectively. Relative power values for each resulting frequency band were computed 
as the ratio of summed absolute band-power to total summed power across the 0.98–29.79 Hz 
range. DAR was computed as the ratio of absolute power for the respective frequency bands of 
interest. These indices were all initially computed separately for each electrode, then were averaged 
over all nineteen scalp electrodes to create “global” QEEG indices as is standard current practice. 
Specific frontal QEEG indices were computed by averaging the respective measures from the four 
lateral frontal electrodes (F3, F4, F7, F8). These electrode locations were chosen given that the 
frontal lobes are critical to various cognitive processes and also because, in MCA and anterior 
circulation strokes at least, scalp delta power is typically highest at these (and adjacent) electrodes 
(Finnigan and van Putten, 2013). In addition Szelies et al (2002) report that delta and alpha power 
measures derived particularly from these (and adjacent) electrodes differed significantly between 
samples of stroke patients whom subsequently had favourable versus unfavourable outcomes 
(Szelies et al., 2002). The fronto-polar electrodes (FP1, FP2) are not included in our frontal analyses 
because the above does not hold in the case of these, and we aimed to constrain this analysis to a 
few electrodes, plus they generally are relatively more susceptible to artefacts (including those 
caused by eye movements or blinks), as discussed elsewhere (Finnigan and van Putten, 2013). 
QEEG indices averaged across the four corresponding lateral posterior electrodes (P3, P4, T5, T6) 
were also analysed, for comparison with results from frontal indices. 
 
van Putten and Tavy, (2004) were the first to investigate the brain symmetry index (BSI) in stroke 
studies and found it to correlate with concomitant NIHSS in acute ischaemic stroke (van Putten and 
Tavy, 2004). Another study reported it to be sensitive to cerebral pathophysiology in subcortical 
stroke, as compared to healthy controls (Molnar et al., 2006). Variants of this BSI have since been 
applied in other studies (see Finnigan and van Putten, 2013). We used the pairwise derived brain 
symmetry index (pdBSI) as employed in a recent study (Sheorajpanday et al., 2011). This was 
calculated across the 0.98–24.90 Hz frequency range using 8 pairs of homologous electrodes (Fp1–
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Fp2; F3–F4; C3–C4; P3–P4; O1–O2; F7–F8; T3–T4; T5–T6). Interhemispheric amplitude 
(a)symmetries in individual electrode pairs were initially calculated and then averaged. Hence the 
global BSI calculation is as follows: 
BSI=[ + + + + + + + ] /8 
In addition a frontal pdBSI was calculated as the average of the two lateral frontal, interhemispheric 
electrode pairs (F3–F4 and F7–F8) and; posterior pdBSI was averaged over two lateral posterior 
electrode pairs (P3–P4 and T5–T6). Following computation of each averaged pdBSI value (global, 
frontal, posterior), absolute values were analysed, as these are sensitive to overall degree of 
asymmetry, but not to lateralisation of same. 
 
Outcome assessments 
Post-stroke outcomes were assessed at approximately 3-months post-stroke using the NIHSS and 
FIM–FAM. The FIM–FAM is a multi-dimensional outcome assessment scale comprising 30 items 
which probe cognitive, behavioural, mobility, locomotion, self-care, communication and physical 
functions respectively (Skinner and Turner-Stokes, 2006). The FIM–FAM has been validated, the 
FIM component (at least) is widely used to assess brain injury patients, and the FIM–FAM was 
utilised in a broadly similar study to assess a sample comprising these and stroke patients (Leon-
Carrion et al., 2009). The FIM–FAM was administered by a FIM-certified, senior occupational 
therapist. Each item is scored from 1 to 7 based on the patient's level of functional independence, 
whereby 1 represents total dependence and 7, total independence. Hence a total FIM–FAM score 
(out of a maximum of 210) was summed for each patient. The FIM–FAM includes 5 items each 
assessing the cognitive domains of problem solving, memory, orientation, attention and safety 
judgement, respectively. In addition to the total score a cognition-specific sub-total outcome score 
was also calculated for each patient, as the sum (out of a maximum of 35) across these 5 items. 
 
Statistical analyses 
The various QEEG indices summarised above (global, frontal and posterior) were each correlated 
with two FIM–FAM outcome scores (total and cognitive sub-total). Not all data from the assessed 
variables were normally distributed so non-parametric Spearman's rank correlation coefficient was 
used to compute correlations between QEEG indices and 3-month FIM–FAM measures. In 
assessing the significance of correlation coefficients, the stringent Bonferroni correction for 
multiple comparisons was applied to maintain the total Type I error rate at a sufficiently low level. 
We have employed the same methodology in past studies (Finnigan et al., 2004, Finnigan et al., 
2007). A total of 36 correlation coefficients were computed (6 global, 6 frontal and 6 posterior 
QEEG indices, each compared with two outcome measures), hence correlations were considered 
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significant only when their associated probability value was lower than .0014 (that is, lower than 
.05 divided by 36). 
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2.5 Results 
Patient demographics, including clinical scale scores and hemisphere affected for each patient, are 
summarised in Table 1. Twenty-five patients (13 female, mean age 71, range 38–85 years) were 
recruited. Five patients were excluded from the statistical analyses, 4 of whom died within 3 months 
of stroke and one not assessed with the FIM–FAM due to unavailability of the occupational 
therapist. Hence data from 20 patients (10 female, mean age years, range 38–84) were analysed. Of 
these, 9 suffered ischaemic stroke in the left and 11 in the right, middle cerebral artery (MCA) 
territory. Acute QEEG data (acquired within 10 h of stroke symptom onset) from patients 12 and 15 
have recently been reported (Sheikh et al., 2013). Apart from these, data from no other patients 
included in the current study have been published previously. EEG was recorded at a mean of 73 h 
(range 62 to 101) post-stroke onset. Stroke severity varied from mild to severe as reflected in the 
range of NIHSS scores assessed at approximately 72 h post-stroke (range 0 to 19 in the analysed 
cases; Table 1). Post-stroke outcomes were assessed at a mean of 105 days (range 70–209) post-
stroke (see Table 1). 
 
Results of the correlation analyses are summarised in Table 2. Following Bonferroni correction two 
QEEG indices correlated significantly with cognitive outcome measures, these being frontal DAR 
(ρ = − 0.664, p ≤ 0.001) (Fig. 1C) and global alpha power (ρ = 0.67, p ≤ 0.001) (Fig. 2C). There 
were no significant correlations between any other global, frontal or posterior QEEG indices and 
general outcome measures. 
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ID Age Gender Stroke Territory 
Sub-acute 
NIHSS 
Outcome 
NIHSS 
Outcome 
FIMFAM 
Outcome 
Cognition 
Days post-stroke of 
Outcome Assessment 
1 71 Female R MCA 16 10 97 14 209 
2 79 Female R MCA 11 NA NA NA NA 
3 56 Male R MCA 0 0 194 34 138 
4 82 Female L MCA 2 0 147 32 137 
5* 84 Female L MCA 2 NA NA NA NA 
6 38 Female L MCA 1 0 206 34 94 
7 56 Male L MCA 17 8 158 26 94 
8* 84 Female R MCA 18 NA NA NA NA 
9* 82 Male L MCA 25 NA NA NA NA 
10 45 Male L MCA 19 NA 82 9 118 
11 67 Male R MCA 0 0 210 35 105 
12 74 Female R MCA 4 5 153 35 98 
13 66 Female R MCA 0 0 204 35 83 
14* 85 Male R MCA 19 NA NA NA NA 
15 74 Female L MCA 11 4 78 10 96 
16 81 Male L MCA 5 1 78 31 83 
17 51 Female R MCA 18 8 171 16 119 
18 82 Male R MCA 16 11 96 22 79 
19 79 Female R MCA 9 8 118 29 114 
20 77 Female R MCA 6 6 145 28 112 
21 49 Male L MCA 5 1 190 32 71 
22 79 Female L MCA 7 4 150 17 70 
23 75 Male R MCA 3 2 183 26 92 
24 77 Male R MCA 15 7 74 14 86 
25 84 Male L MCA 1 0 201 33 99 
Table 1. Patient demographics and stroke details 
* = patient deceased by 3 months post-stroke; NA = not assessed; L=left, R=right, MCA= middle cerebral artery  
 
  FIM-FAM total Cognitive sub-total 
Global QEEG Frontal QEEG Posterior QEEG Global QEEG Frontal QEEG Posterior QEEG 
Delta rho −0.604 −0.569 −0.624 −0.583 −0.558 −0.653 
 p .005 .009 .003 .007 .011 .002 
Theta rho −0.115 −0.075 −0.277 −0.105 −0.047 −0.149 
 p .629 .753 .237 .660 .845 .530 
Alpha rho 0.61 0.566 0.57 0.67* 0.633 0.571 
 p .004 .009 .009 .001 .003 .009 
Beta rho 0.443 0.38 0.308 0.495 0.446 0.367 
 p .050 .099 .186 .026 .048 .111 
DAR rho −0.545 −0.566 −0.587 −0.613 −0.664* −0.637 
 p .013 .009 .007 .004 .001 .003 
pdBSI rho −0.344 −0.274 −0.187 −0.422 −0.491 −0.272 
 p .138 .243 .429 .064 .028 .246 
Table 2: Correlations between pre-discharge QEEG indices and cognitive and general outcome assessed by the FIM-
FAM. 
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Figure 1. Scatterplots illustrating the correlations between FIM-FAM and frontal relative delta power (A), frontal 
relative alpha power (B) and frontal DAR (C) 
 
   
   
Figure2. Scatterplots illustrating the correlations between FIM-FAM and global relative delta power (A), global relative 
theta power (B), global relative alpha power (C) and global relative beta power (D) 
 
Following Bonferroni correction, no significant correlations were retained between posterior QEEG 
indices and outcome measures. However strong negative correlations were observed between 
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cognitive outcomes and both posterior, relative delta (ρ = − 0.653, p = 0.002) and posterior DAR (ρ 
= − 0.637, p = 0.003). A similarly strong negative correlation was observed between FIM–FAM 
general outcome scores and posterior, relative delta (ρ = − 0.624, p = 0.003). Finally, frontal alpha 
power demonstrated a strong positive correlation with cognitive outcome scores (ρ = 0.633, p = 
0.003). 
 
Although not all such correlations were significant after correction, consistent with past studies 
analysing other outcome measures (Finnigan et al., 2007), QEEG-outcome correlations were 
positive in the case of relative alpha power, and negative for both relative delta and DAR. That is, 
greater proportional delta power (and DAR) and lower proportional alpha power were generally 
associated with poorer functional outcomes. Such outcomes were observed not only for global 
delta/alpha and generalised functional outcomes measures (as reported in past studies analysing 
NIHSS or Modified Rankin Scale (disability measure)) but also, for frontal and posterior delta/alpha 
measures as well as for cognition-specific outcome measures. The latter series of results have not 
been reported previously. 
 
There were no significant correlations between pdBSI (calculated from global, frontal or posterior 
electrode montages) and FIM–FAM outcome measures. The correlation between the frontal (but not 
global or posterior) pdBSI and cognitive outcome scores was significant only prior to Bonferroni 
correction (ρ = − 0.491, p = 0.028), but was substantially weaker than the bandpower-related 
correlation outcomes summarised above. This was a negative correlation indicating that a greater 
degree of interhemispheric power asymmetry between left and right frontal electrode pairs (F3–F4 
and F7–F8) was generally associated with poorer cognitive outcome scores, and vice versa. 
Somewhat surprisingly, no significant correlations were observed between relative theta power and 
outcome measures (even prior to Bonferroni correction). Finally, as for pdBSI, no significant 
correlations involving relative beta power were observed following correction. 
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2.6 Discussion 
In a sample of twenty cases of ischaemic stroke in the middle cerebral artery (MCA), a highly 
significant correlation was obtained between frontal, delta/alpha ratio (DAR) assessed at 
approximately 72 h post-stroke onset and cognitive outcome measures assessed at mean 3.5 months 
post-stroke (Fig. 1C). Interestingly, this correlation was stronger than the non-significant correlation 
between cognitive outcomes and global DAR (computed from all nineteen electrodes). This is the 
first report of a correlation between post-stroke outcomes and a QEEG index derived from only 
several electrodes, and of correlations between post-stroke cognitive measures and QEEG. 
Moreover these novel observations indicate that DAR derived from only four frontal electrodes 
could potentially inform early screening for post-stroke deficits. In turn this could inform clinical 
decisions regarding, for example, rehabilitation strategies, return to work, or required levels of care. 
This warrants further investigation in larger samples. 
 
The cognitive items of the FIM–FAM scale analysed here assess memory, executive function (e.g., 
problem solving), orientation, awareness and attentional capacities. The frontal lobes are critical for 
such cognitive processes (Stuss, 2002), plus abnormal delta power is typically highest at lateral 
frontal (and temporal) electrodes in MCA strokes (Finnigan and van Putten, 2013) . As such the 
significant correlation between frontal DAR and cognitive outcomes may not seem particularly 
surprising. Although alpha power typically has a posterior maximum, at least in healthy adults, so 
the potential contribution of frontal alpha activity to that correlation warrants consideration. Frontal 
alpha power was strongly correlated with cognitive outcomes (ρ = 0.63): although this was not 
significant after correction it was substantially stronger than the correlation involving posterior 
alpha. These results indicate that degree of post-stroke, frontal alpha activity is particularly 
important regarding prognostication of cognitive outcomes (see below). Further, the findings that 
the latter correlated significantly with frontal DAR but not frontal delta or frontal alpha power per 
se, is consistent with the proposal (Finnigan et al., 2007) that DAR, being sensitive to both 
abnormal delta and normative alpha activity, is more effective for post-stroke prognostication than 
either bandpower measure alone. 
 
The only other significant correlation was between cognitive outcomes and global, relative alpha 
power (computed from all nineteen electrodes). Alpha activity has been linked to various aspects of 
information processing and cognition, particularly attention (Klimesch, 2012). As noted above, 
frontal cortical regions support attention and the other cognitive processes analysed here, and 
frontal alpha was more strongly associated with cognitive outcomes than posterior alpha. Further, 
post-stroke attentional capacity (assessed at two months) has been shown to independently correlate 
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with general functional and motor activity outcomes, assessed at two years (Robertson et al., 1997). 
Hence alpha activity – particularly frontal alpha – may index post-stroke attentional capacity, which 
in turn is a key determinant of functional and cognitive outcomes from ischaemic stroke (at least in 
the MCA territory). This, together with the frontal focus of delta in MCA strokes, is also consistent 
with the significant correlation between cognitive outcomes and frontal DAR. 
 
All correlations between outcome and pdBSI measures were non-significant, and were substantially 
weaker than those involving delta and/or alpha power measures. These results indicate that degree 
of post-stroke, interhemispheric voltage (a)symmetry is not strongly associated with cognitive 
outcomes. Somewhat surprisingly, the correlation coefficients involving relative theta power were 
yet weaker again. Although consistent with past stroke studies which did not assess cognition 
(Nuwer et al., 1987, Finnigan et al., 2007) these results are curious given that (frontal) theta activity 
is known to be associated with various aspects of cognitive function, in healthy adults (Cummins 
and Finnigan, 2007, Cummins et al., 2008) (for review see (Mitchell et al., 2008) and in those with 
mild cognitive impairments (Cummins et al., 2008). Likewise, in a large sample of healthy older 
adults frontal, relative theta (but neither delta nor alpha) power correlated significantly with several 
standardised cognitive measures (Finnigan and Robertson, 2011). The current results may be due 
(in part) to the generalised phenomenon of EEG slowing post-stroke, whereby “slowed alpha” 
activity may sometimes confound theta power measures (Finnigan and Robertson, 2011). Future 
studies may investigate this further but regardless, theta power measures do not seem informative in 
relation to post-stroke functional or cognitive outcomes. 
 
EEG is widely available, non-invasive, inexpensive and without contraindications. QEEG provides 
objective measures of brain (dys)function even in patients with language, visual, hearing or 
functional impairments, such as dense loss of upper limb, who are not able to fully complete the 
screening scales such as the Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005). 
Four electrodes can be applied in minutes, contemporary clinical EEG systems automatically 
display QEEG indices such as those analysed here, and reliable indices are computed from 2 to 3 
min of EEG. EEG expertise remains important (e.g. for artefact identification), and this can be 
accessed remotely (using telemedicine technology) if required. 
 
The current study has potential limitations, including a relatively modest sample size (albeit larger 
than some of the studies cited herein). A specific cognitive outcome assessment (such as the 
MoCA) has not been used, although this is a future aim and this is not the first study to analyse 
cognitive sub-total scores from the FIM (Gialanella and Ferlucci, 2010, Gialanella, 2011). The 
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FIM–FAM is reliable and a very commonly used outcome measure in stroke rehabilitation. Future 
studies may also compare correlations between cognitive outcomes (assessed by e.g. MoCA) and 
other pre-discharge assessment measures, such as MRI-defined lesion volumes. Ultimately a 
combination of such variables (e.g., frontal DAR, MoCA, lesion volume) may well prove more 
prognostically accurate than any such variable alone. Patients did not have further imaging at 
follow-up to assess potential progressive pathophysiology. However the longitudinal NIHSS scores 
(see Table 1) from 20 cases indicate that only one patient had a higher NIHSS (5) at follow-up than 
at the time of EEG (4). These observations indicate that these 20 cases did not include any of 
progressive strokes, albeit longitudinal imaging data could help confirm this and such topics may be 
investigated in future studies. Finally future studies may also assess depression-related outcomes, 
which are evidently linked to post-stroke cognitive impairment (Nys et al., 2006). 
 
In summary, the current results indicate that DAR acquired from four frontal electrodes prior to 
discharge from stroke units, may uniquely inform early screening for post-stroke cognitive deficits 
and associated clinical decisions (in ischaemic MCA stroke patients, at least). Further studies 
incorporating larger samples (and other stroke locations) and additional assessment measures are 
warranted. 
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CHAPTER 3 
POST-STROKE COGNITIVE IMPAIRMENT: THE ACCURACY OF A PRE-
DISCHARGE EEG MARKER SCREENING MEASURE 
 
3.1 Abstract 
Following on from findings of the previous chapter establishing pre-discharge QEEG as a potential 
indicator of subsequent post-stroke cognitive impairment, the aim of this study was to develop a 
model to screen for or detect post-stroke cognitive impairment using QEEG indices as predictor 
variables and the Montreal Cognitive Assessment (MoCA) as the measure of cognitive function.  In 
the previous chapter the FIM-FAM was used to index cognitive function at 3-months post-stroke, in 
this study the MoCA will be used instead. The MoCA was developed specifically to assess mild 
cognitive impairment (MCI) in an older population (Nasreddine et al., 2005) and it is effective in 
screening for cognitive impairment in post-stroke populations (Dong et al., 2010, Dong et al., 2012, 
Pendlebury et al., 2012a). Clinically the MoCA is routinely used and as such the results of the study 
assessing the screening capabilities of QEEG will be more meaningful to clinicians. In addition the 
MoCA items are adapted from cognitive assessments commonly used in neuropsychological 
testing. This study comprises data from 38 patients; data from 4 of these patients were included in 
the previous study (Chapter 2), data from the remaining 32 patients included in the study are 
previously unreported. 
 
Resting-state, 19-electrode, pre-discharge EEG was recorded at the bedside within 48-239h after 
onset of symptoms of middle cerebral artery (MCA) territory, ischaemic stroke (confirmed 
radiologically). Relative power for delta, theta, alpha and beta frequencies, delta:alpha ratio (DAR) 
and peak alpha frequency (PAF) were averaged over frontal polar (Fp1-Fp2), frontal (F7-F3-Fz-F4-
F8), centrotemporal (T3-C3- -C4-T4), parietotemporal (T5-P3-Pz-P4-T6) and occipital regions (O1-
O2).  Cognitive function was assessed at approximately 3-months post-stroke (median: 99 days 
post-stroke, range 69-138 days). MoCA scores were correlated with QEEG indices using 
Spearman's coefficient. Binary logistic regression was used to build a QEEG screening model to 
classify cognitive impairment. Outcome MoCA scores out of 30 were dichotomised, scores ≤25 
indicate cognitive impairment. 
 
Thirty-one patients (10 female, age range: 18-84) were included in the analyses.  High posterior 
relative theta frequency power was significantly correlated with low outcome MoCA scores.  Low 
PAF was significantly correlated with low MoCA scores.  Centrotemporal and occipital relative 
41 
theta frequency power were selected as predictor variables and were able to accurately 
prognosticate cognitive impairment in 81% of the sample (25/31). 
 
Power in the classical upper theta frequency range and PAF were identified as the most informative 
measures of post-stroke cognitive impairment particularly in the posterior regions of the scalp. 
These results support the view that these QEEG measures reflect alpha slowing, and are indicative 
of post-stroke cognitive outcomes. Relative power in the theta frequency range from 6 posterior 
electrodes was able to accurately classify 81% of participants.  QEEG screening measures could be 
used in addition to pen and paper assessments like the MoCA where possible to improve screening 
measures and especially in cases where patients are unable to complete such assessments. 
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3.2 Introduction 
The early and accurate detection of cognitive deficits following stroke is imperative for informing 
patient care needs and rehabilitation planning and goals.  Brief pen and paper tests such as the 
Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) are 
commonly used to screen for cognitive impairment in acute stroke. When these tests are used on 
suitable patients, they are reported to be effective in detecting post-stroke cognitive impairment 
(Dong et al., 2012, Freitas et al., 2012, Pendlebury et al., 2012a). Pen and paper tests are, however, 
poorly suited to the condition of many acute stroke patients. Common post-stroke conditions such 
as upper-limb paraesthesia and weakness, visual impairment, aphasia and fatigue may preclude full 
participation in pen and paper testing. There remains a need for a feasible method to detect early 
cognitive deficits that is robust to the clinical condition of acute stroke patients while remaining 
comparable to brief cognitive tests. 
 
Quantitative electroencephalography (QEEG) presents as a potential method to capture and screen 
for functional cognitive deficits prior to hospital discharge.  EEG recording is well suited to the 
various symptomologies associated with testing acute stroke patients (Finnigan and van Putten, 
2013).  EEG recordings, unlike pen and paper tests, do not require patients to participate in testing 
procedure, they are not subject to retest learning effects (like pen and paper tests may be) and 
QEEG indices provide objective measures of brain function.  Recordings can be carried out at 
bedside, accommodating for difficulties in transporting patients and adapting well to the conditions 
of acute stroke. 
 
The relationship between pre-hospital discharge QEEG indices and functional cognitive outcome in 
stroke patients was established in the preceding chapter (Schleiger et al., 2014).  Pre-discharge 
QEEG indices from just four frontal electrodes were strongly and significantly correlated with 
cognitive function as measured by the Functional Independence and Functional Assessment 
Measure (FIM-FAM) at 3-months post-stroke. Specifically a decrease in pre-discharge, faster 
frontal alpha frequency power in concert with an increase in frontal slower delta frequency power 
(as measured by the delta:alpha ratio (DAR)) correlated strongly and significantly with greater 
degree of functional cognitive impairment at 3-months post-stroke.  These results suggest that pre-
discharge QEEG indices may index cognitive deficits at 3-months post-stroke.   
 
Aside from the aforementioned Schleiger et al. (2014) study, some investigation in the value of 
(Q)EEG in detecting cognitive deficits has been reported. One study investigated QEEG indices in 
105 post-stroke patients (Song et al., 2014).  Patients with high theta frequency power were found 
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to have greater incidence of cognitive impairment than those with lower power (Song et al., 2014). 
However, the details of this study are somewhat ambiguous, such as when EEG was recorded and 
when MoCA was assessed as well as whether test-retest protocols regarding the MoCA were 
adhered to. Another group recorded EEG in 199 patients within 48 hours of stroke and assessed 
cognition using the Short Mental Test every 6-months for two-years (Gur et al., 1994).  EEG was 
classified as normal or abnormal based on focal and diffuse slowing.  Patients with abnormal EEG 
had 2.6 times the risk of developing dementia within two years than those with normal EEG 
recordings (Gur et al., 1994).  These studies suggest that both slower theta band activity and 
slowing of faster alpha band activity may be indicative of post-stroke cognitive impairment. 
 
Alpha frequency activity was also identified as a measure of interest regarding the detection of 
cognitive impairment in Parkinson’s patients.  Bousleiman et al. (2014) developed a cut-off value in 
the alpha frequency band to classify Parkinson’s patients as cognitively impaired or normal.  They 
report that decreased power in the alpha band (between 8-10Hz) in the temporal region was the 
strongest marker of cognitive impairment in Parkinson’s patients and propose this as a potential 
biomarker of cognitive impairment (Bousleiman et al., 2014).  In addition the same research group 
used a linear regression model to assess the relationship between EEG slowing and several 
cognitive domains.  The degree of EEG slowing in Parkinson’s patients was strongly associated 
with cognitive performance in attention, executive functions, fluency and memory with increased 
slowing associated with poorer performance (Zimmermann et al., 2015). Past studies in stroke and 
non-stroke populations alike indicate that both alpha and theta frequency, including measures of 
slowing, are of interest when screening for and prognosticating cognitive impairment. 
 
In the previous chapter the FIM-FAM was used to index cognitive function at 3-months post-stroke, 
in this study the MoCA will be used instead. The MoCA was developed specifically to assess mild 
cognitive impairment (MCI) in an older population (Nasreddine et al., 2005) and it is effective in 
screening for cognitive impairment in post-stroke populations (Dong et al., 2010, Dong et al., 2012, 
Pendlebury et al., 2012a). Clinically the MoCA is routinely used and as such the results of the study 
assessing the screening capabilities of QEEG will be more meaningful to clinicians. In addition the 
MoCA items are adapted from cognitive assessments commonly used in neuropsychological 
testing.  
 
The aim of this study was to identify any relationships between pre-discharge QEEG indices and 
cognitive function measured using the MoCA.  In addition the accuracy of QEEG indices to inform 
prognostication of post-stroke cognitive impairment was investigated.  Based on previous research 
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outlined above it was expected that delta and theta frequencies along with alpha frequency and 
alpha frequency slowing would be the most informative measures of post-stroke cognitive 
impairment.  In addition, a receiver operating characteristic (ROC) curve analysis of select QEEG 
predictor variables was used to identify optimal cut-off scores to classify cognitive impairment in 
the sample. 
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3.3 Methods 
Patients 
Approval to carry out the study was obtained from the local University and Hospital Human 
Research Ethics Committees. Written informed consent from each patient or substitute decision 
maker was obtained. Patients were recruited from the Royal Brisbane and Women’s Hospital acute 
stroke unit between December 2012 and July 2015.  Patients who were under the age of 18 years or 
pregnant were excluded from participating in the study.  Patients with radiologically confirmed 
middle cerebral artery (MCA) territory ischaemic stroke were included in this analysis.  All patients 
underwent acute non-contrast computed topography (NCCT) scanning and the majority of cases had 
CT perfusion scanning.  When clinically required, patients who were eligible underwent additional 
magnetic resonance imaging (MRI).  Time and date of stroke was documented using the time of 
symptom onset.  In cases of wake-up strokes, time of onset was documented as the mid-point 
between time to bed (no symptoms) and time of wake-up (with symptoms). 
 
Pre-discharge EEG  
Eyes closed resting state EEG was recorded at bedside in the acute stroke unit within 10 days of 
stroke symptom onset.  EEG was recorded using a NicOne Brain Monitor system (Natus Medical 
Inc.) with a sampling rate of 500 Hz. Nineteen Ag/Ag–Cl electrodes (Nicolet) were applied 
according to the International 10–20 system (Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, 
T4, T5, T6, Fz, Cz, Pz) a reference electrode was positioned between Fz and Cz and a ground 
electrode was positioned on the collarbone.  Electrode impedances were primarily between 5–10 kΩ 
or less.  EEG was recorded for approximately 10-15 minutes and alertness/sleepiness was assessed 
behaviourally throughout the duration of the recordings. 
 
Cognitive and functional assessment 
Pre-discharge assessments were carried out on the same day as the EEG recording, within 10 days 
of stroke.  Outcome assessments were carried out at approximately 3-months post-stroke.  Each 
measure was assessed at both pre-discharge and outcome.  Stroke severity was assessed using the 
National Institute of Health Stroke Scale (NIHSS).  Disability was assessed using the modified 
Rankin Scale (mRS). Cognitive impairment was assessed with the Montreal Cognitive Assessment 
(MoCA). The MoCA is a brief cognitive screening assessment scored out of 30, patients with scores 
≥26 are considered to have normative cognitive function.  The MoCA assesses several domains of 
cognition including: executive processing, memory, attention, language, and orientation.  Version 1 
and 2 of the MoCA, which contain slight variations of the same questions, were used at pre-
discharge and outcome assessments respectively to avoid learning effects. 
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EEG analysis 
EEG signal processing and analysis was performed offline using Curry Neuroimaging Suite 7.0.8 
(Compumedics Neuroscan).  For each participant EEG recordings were filtered (lowpass 35Hz 
Slope 8Hz, where necessary a 35Hz notch filter was also used) and segmented into 4096ms duration 
epochs.  Data was baseline corrected and referenced to the Cz electrode. Cz was selected as the 
reference electrode rather than the common average electrode often used in QEEG studies.  This 
was to minimise any impacts and/or contributions of electrodes not included in the regional 
calculations. The first 45 epochs (3 minutes) of clean EEG were selected and averaged.  The Fast 
Fourier transform was used to calculate the power spectra which resulted in a value for each 0.12Hz 
iteration at each electrode. 
 
Absolute power was summed across the delta (0.98–3.91 Hz), theta (4.15–7.57 Hz), alpha (7.81–
12.45 Hz) and beta (12.70–30.03 Hz) bands (inclusive).  For each electrode the following analyses 
were then calculated from these raw values; relative delta, theta, alpha and beta power and 
delta:alpha ratio (DAR).  In addition the peak alpha frequency (PAF) was assessed as a measure of 
alpha slowing as performed and recommended by Finnigan et al. (2011).  PAF values were 
calculated by identifying the frequency between 5.62-12.45Hz with the highest peak in power. A 
lower frequency threshold of 5.62Hz was chosen to account for alpha slowing while avoiding 
inclusion of the delta peak.  Average power was calculated for each above listed frequency measure 
across: frontal polar (Fp1-Fp2), frontal (F7-F3-Fz-F4-F8), centrotemporal (T3-C3-C4-T4), 
parietotemporal (T5-P3-Pz-P4-T6) and occipital regions (O1-O2) (Figure 1). 
 
 
Figure 1. Head plot showing regional electrode groupings 
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Statistical Analysis 
All data were analysed using SPSS statistical package (IBM SPSS Statistics, Version 22). Spearman 
correlation coefficients were calculated to investigate which QEEG indices (relative delta, theta, 
alpha, beta frequency power, DAR and PAF calculated across each of the 5 regions) significantly 
correlated with the 3–month MoCA scores.  Any correlation with p≤0.05 was considered 
significant; correction for multiple comparisons was not used. Perneger (1998) outlines the limited 
value of corrections for multiple comparisons (such as the Bonferroni correction) including 
increased type II errors and that interpretations of findings should not be dependent on the number 
of tests performed, instead Perneger advises the use of careful explanation of results and limitations 
in studies (Perneger, 1998). 
 
Forward stepwise binary logistic regression was used to assess the efficacy of QEEG indices in 
screening for cognitive impairment. Forward stepwise modelling involves successively adding or 
removing variables from the model based on the t-statistics of their estimated coefficients.  This 
method is well suited to developing a parsimonious model when there are several potential predictor 
variables. Cognitive impairment was indexed using dichotomised outcome MoCA scores. Patients 
with a score of ≤25 were considered to have a degree of cognitive impairment and those with a 
score of ≥26 were considered to have normative cognitive function (Nasreddine et al., 2005).  A 
second binary logistic regression analysis was analysed using pre-discharge MoCA scores instead 
of QEEG measures as the predictor variable. Pre-discharge MoCA assessments are a commonly 
used screening tool for cognitive impairment and as such are an appropriate benchmark with which 
to compare the QEEG model. 
 
A receiver operating characteristics (ROC) curve analysis was used to identify optimal cut-off 
scores for each of the QEEG predictor variables identified in the QEEG regression model.  The cut-
off scores determine the value at which each predictor has maximal sensitivity and specificity. 
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3.4 Results 
Descriptive statistics and demographics 
Thirty-eight patients were recruited of which 1 was excluded due to prominent bilateral infarction, 2 
were excluded as outliers based on their documented alcohol abuse, 3 participants were unable to 
attend the follow-up assessment and 1 participant could not complete the follow-up MoCA due to 
visual impairments.  The remaining 31 participants (10 female, age range: 18-84) were included in 
the subsequent analyses, demographic information including stroke severity and MoCA scores are 
documented in Table 1.  Pre-discharge assessment including EEG recording, MoCA, NIHSS and 
mRS were carried out at median 90 hours post stroke symptom onset (range 48-239 hours).  
Outcome assessments including MoCA, NIHSS and mRS were carried out at median 99 days post 
stroke (range 69-138 days).   
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ID 
Stroke 
Territory 
Age Gender 
MoCA 
(pre-discharge) 
MoCA 
(outcome) 
NIHSS 
 (pre-discharge) 
NIHSS 
(outcome) 
mRS   
(pre-discharge) 
mRS 
(outcome) 
1 R MCA 77 M 26 26 3 1 1 1 
2L L MCA 84 M 15 21 1 0 1 0 
3 L MCA 47 M 13 22 3 0 2 0 
4L R MCA 72 M 20 23 10 1 4 1 
5W L MCA 78 F 25 24 0 0 0 0 
6 L MCA 49 M NA 27 5 1 2 2 
7L L MCA 79 F NA 14 7 4 4 4 
8L R MCA 77 M NA 15 15 7 5 4 
9 L MCA 74 M NA 22 3 0 1 2 
10WL L MCA 54 M 28 30 0 0 0 0 
11 L MCA 65 M 26 29 1 0 1 0 
12 R MCA 18 F 28 30 0 0 1 1 
13 L MCA 61 M 24 27 0 0 2 0 
14 R MCA 72 F 21 21 1 0 1 2 
15L R MCA 52 M NA 27 21 13 5 4 
16L R MCA 66 M 22 28 7 3 4 3 
17 R MCA 67 M 18 24 5 1 3 2 
18W R MCA 71 F 11 25 2 1 3 0 
19W R MCA 61 F 25 28 4 1 3 1 
20W R MCA 78 F 15 20 19 7 5 3 
21 R MCA 69 F 27 27 0 1 1 1 
22 R MCA 74 M 23 25 0 1 1 2 
23 R MCA 66 M 23 23 0 0 0 1 
24W L MCA 67 M 28 29 0 0 0 0 
25W R MCA 81 F 18 23 1 0 2 1 
26 R MCA 46 M 29 29 0 0 0 0 
27W R MCA 69 M 24 27 1 0 1 0 
28 L MCA 53 M NA 27 0 0 1 1 
29W R MCA 57 M 26 26 1 0 1 0 
30WL R MCA 72 F 15 14 2 1 3 2 
31 R MCA 69 M 26 27 0 0 2 0 
Table 1. Patient demographics and stroke details 
R MCA: Right middle cerebral artery, L MCA: Left middle cerebral artery 
L: Patient received tissue plasminogen activator (rtPA) W: Patient had wake-up stroke 
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Of the 38 patients recruited for the study, 5 (13%) were unable to complete the pre-discharge 
MoCA due to impairments, 4 with upper limb hemiparesis and weakness and 1 with visual 
impairments (in addition 4 were unable to complete the pre-discharge MoCA due to recruitment 
issues).  Of the 29 patients who completed the pre-discharge MoCA, 18 were classified as 
cognitively impaired (MoCA score ≤25) and 11 as normative (MoCA score ≥26).  At the outcome 
assessments 15 patients were classified as having a cognitive impairment and 16 were classified as 
normative.  Twenty-seven patients completed both the pre-discharge and outcome MoCA 
assessments, of those 24 had improved or stable scores across the 3-months, 3 patients’ scores 
worsened (Figure 2).  The largest difference in performance between pre-discharge and outcome 
assessments was seen in a patient with a pre-discharge score of 11 and an outcome score of 25.   
 
 
Figure 2. Interaction plot showing changes in MoCA scores between pre-discharge and outcome assessments 
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Correlation analysis between pre-discharge variables and outcome MoCA score 
Spearman correlation coefficients were used to assess the relationship between pre-discharge 
variables (including QEEG indices, age, gender, MoCA, NIHSS and mRS) and outcome MoCA 
performance.  Significant results (p≤0.05) of the correlation analyses are summarised in Table 2.  
Higher posterior relative theta frequency power was significantly associated with lower outcome 
MoCA scores.  This relationship was significant in the occipital (Figure 3) and parietotemporal 
regions.  There was also a significant relationship between relative theta frequency power in frontal 
polar regions and MoCA score.  PAF was significantly correlated with outcome MoCA score in all 
regions except frontal polar.  Lower PAF, indicating alpha slowing, was associated with lower 
outcome MoCA scores.  Outcome MoCA scores were also significantly associated with age, pre-
discharge MoCA, NIHSS and mRS scores.  There were no significant relationships between gender 
and outcome MoCA scores.  There were no significant relationships between relative delta, alpha or 
beta frequency power or DAR in any regions and MoCA outcome score. 
 
Pre-discharge variable  Spearman correlation coefficient 
Age r=-0.692** 
Pre-discharge MoCA r=-0.824** 
Pre-discharge NIHSS r=-0.432* 
Pre-discharge mRS r=-0.380* 
Frontal polar relative theta power (Fp1-Fp2) r=-0.394* 
Parietotemporal relative theta power (T5-T6-P3-Pz-P4) r=-0.494* 
Occipital relative theta power (O1-O2) r=-0.584** 
Frontal peak alpha frequency r=0.353* 
Centrotemporal peak alpha frequency r=0.532** 
Parietotemporal peak alpha frequency r=0.528** 
Occipital peak alpha frequency r=0.434* 
Table 2. Significant Spearman correlation coefficients between pre-discharge variables and outcome 
MoCA scores 
*p≤0.05 significance, **p≤0.001 significance 
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Figure 3. Scatterplot of the relationship between pre-discharge occipital relative theta frequency power and outcome 
MoCA score 
 
QEEG Regression Model 
A logistic regression analysis was carried out to predict cognitive impairment following stroke 
using QEEG indices as predictors.  Outcome MoCA scores were dichotomised as normal or 
cognitively impaired as described earlier.  Forward stepwise method of predictor variable selection 
was used.  All QEEG indices including: relative delta, theta, alpha, beta frequency power, DAR and 
PAF across frontal polar (Fp1-Fp2), frontal (F7-F3-Fz-F4-F8), centrotemporal (T3-C3-Cz-C4-T4), 
parietotemporal (T5-P3-Pz-P4-T6) and occipital regions (O1-O2) were entered for possible 
selection in the model.  Two QEEG indices, centrotemporal and occipital relative theta frequency 
power, were selected as the best predictors of cognitive impairment in the regression model.  In the 
final model both QEEG predictor variables were standardised by multiplying the QEEG power 
values by 100. 
 
A test of the full model against the constant only model was significant, indicating that pre-
discharge centrotemporal and occipital relative theta frequency power reliably distinguished 
between the presence or absence of subsequent cognitive impairment as measured by the MoCA. 
Nagelkerke’s R2 of 0.442 indicates a moderate relationship between the predictors with the outcome 
variable.  The model classified 81% of the cases correctly (80% correctly identified as cognitively 
impaired and 81% correctly identified as normal).  Occipital relative theta power independently 
contributed significantly to the model, centrotemporal relative theta power did not significantly 
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contribute independently to the model, however, does account for unique variance as a predictor, 
see Table 3. 
 
Independent Variables b OR (95% CI) Significance 
Centrotemporal relative theta power 0.234 0.791 (0.619-1.011) 0.061 
Occipital relative theta power 0.347 1.415 (1.063-1.883) 0.017 
χ2(2)=12.467, p<.01 
Table 3.Coeficiants of the QEEG model predicting post-stroke cognitive impairment 
OR: odds ratio, b: Beta value 
 
There were 6 out of 31 patients included in the model who were incorrectly classified based on the 
QEEG model.  Four of the misclassified patients had percentage changes in pre-discharge and 
outcome MoCA scores between 12% and 127%, the other 2 patients had no change in scores. At 
this point, there are no clear patterns in age, gender, level of impairments across all 6 patients 
discerning the reason for misclassification in the regression model. 
 
Pre-discharge MoCA regression model 
A second regression model was built using pre-discharge MoCA scores to classify patients ,as 
cognitively impaired using dichotomised outcome MoCA scores of the 25 patients included in the 
analyses, who were able to complete both the pre-discharge and outcome MoCA assessments.  This 
model was developed as the basis on which to compare the efficacy of the QEEG model; pre-
discharge MoCA assessments are commonly used to assess post-stroke cognitive impairment.  A 
test of the full model against the constant only model was significant, indicating that pre-discharge 
MoCA reliably distinguished between the presence or absence of subsequent cognitive impairment. 
Nagelkerke’s R2 of 0.797 indicates a moderately strong relationship between the predictor (pre-
discharge MoCA score) and outcome variables (outcome MoCA score) (Table 4).  The model 
classified 92% of the cases correctly (92% for cognitively impaired and 92% for normal).  There 
were 2 out of the 25 patients included in the model who were incorrectly classified based on their 
pre-discharge MoCA score. 
 
The pre-discharge MoCA model was slightly more accurate than the pre-discharge QEEG model in 
classifying post-stroke cognitive impairment (81% versus 92%), 
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Independent Variable b OR (95% CI) Significance 
Pre-discharge MoCA score -0.958 0.384 (0.163-0.901) 0.028 
χ2(1)= 22.731, p<.001 
Table 4. Coefficients of the MoCA model predicting post-stroke cognitive impairment 
OR: odds ratio, b: Beta value 
 
ROC curve analysis 
Cut-off values for occipital and centrotemporal relative theta frequency power were assessed using 
a receiver operating characteristic (ROC) curve.  The ROC curve helps to identify the optimal value 
of predictor variables to adopt as a cut-off between impaired and normal outcomes with maximal 
sensitivity and specificity.  The maximum area under the curve (AUC) is 1 and the closer the AUC 
is to 1, the better the predictor is at discriminating between impaired and normal patients. The AUC 
for occipital relative theta power was 0.783 (p<.01, 95% CI: 0.617-0.950) and 0.625 (p>.05, 95% 
CI: 0.425-0.825) for centrotemporal relative theta frequency power (Figure 4).  Occipital relative 
theta frequency power greater than 14.760/100 was identified as the optimal cut-off mark to 
indicate cognitive impairment (sensitivity of 0.800 and a specificity of 0.750). Centrotemporal 
relative theta frequency power greater than 13.870/100 was identified as the optimal cut-off mark to 
indicate cognitive impairment (sensitivity of 0.667 and a specificity of 0.625).  
 
 
Figure 4. ROC curve using QEEG predictor variables: occipital and centrotemporal relative theta frequency power 
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3.5 Discussion 
Summary of results 
Cognitive function tended to remain stable or improve between the pre-discharge and outcome 
assessments (approximately 3-months post-stroke) in the majority of participants (see Figure 2). 
Higher relative pre-discharge power in the classical upper theta frequency range in posterior regions 
(occipital and parietotemporal regions) tended to be associated with worse performance on the 
MoCA at 3-months post-stroke.  This relationship was also found in frontal polar electrodes. Lower 
PAF in frontal, centrotemporal, parietotemporal and occipital regions was also significantly 
associated with lower MoCA scores. 
 
In the pre-discharge QEEG regression model, relative centrotemporal and occipital power in the 
classical upper theta frequency range were selected as optimal predictors of subsequent cognitive 
impairment.  Using both predictors the model was able to correctly classify 81% patients as 
cognitively impaired or normative.  To assess the classification accuracy of this QEEG model it was 
compared to a pre-discharge MoCA model.  The MoCA model was able to correctly classify 92% 
of the patients who were able to complete both the pre-discharge and outcome MoCA assessments 
in full.  A ROC curve analysis was calculated to evaluate optimal the cut-off values for the QEEG 
regression model predictor variables to identify those with cognitive impairment. Relative occipital 
power in the upper theta frequency range greater than 0.148 µV was identified as the optimal cut-
off mark to indicate cognitive impairment. Relative centrotemporal power in the upper theta 
frequency range greater than 0.139 µV was identified as the optimal cut-off mark to indicate 
cognitive impairment. 
 
Relative theta power and cognitive impairment 
Relative power in the classical upper theta frequency range was identified through the correlation 
and regression analyses as one of the primary (pre-discharge) frequencies related to cognitive 
impairment at 3-months post-stroke.  This relationship was predominantly seen in posterior regions 
but also in frontal polar electrodes.  Although activity in the theta frequency is associated with 
cognitive processing (Klimesch, 1999) it is postulated that power in this frequency range in the 
current study is actually reflective of alpha slowing. Finnigan et al. (2011) suggest that “two forms 
of theta-frequency oscillations may exist; one indicative of healthy neurocognitive function and the 
other, EEG/alpha slowing linked to (future) substantial cognitive decline”.  In clinical populations 
(represented in the current study) increased power in the classical upper theta frequency band is 
actually reflective of alpha slowing and indicative of cognitive impairment.  Whereas in healthy 
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(non-stroke) populations increased upper theta frequency activity is not due to slowing and is 
instead indicative of better cognitive function. 
 
The theory that one ‘form’ of theta frequency oscillations are actually due to the influence of alpha 
slowing is supported by several past studies.  Increased activity in the theta frequency has been 
reported in older mild cognitively impaired (MCI) and dementia populations in comparison to 
healthy controls (Jelic et al., 2000, Grunwald et al., 2002).  Resting state EEG was recorded in 319 
elderly patients with cognitive functioning ranging from normal to severely declined (Alzheimer’s 
dementia).  It was found that increases in theta frequency power (particularly in the posterior 
regions of the brain) were significantly associated with increased levels of cognitive impairment as 
measured by the Global Deterioration Scale (Prichep et al., 1994). In these populations increased 
activity in the theta frequency is likely indexing alpha slowing and is associated with cognitive 
decline as was found in the current study. 
 
In support of the other ‘form’ of theta frequency activity, investigations in healthy older samples 
report findings in the opposite direction; increased activity in the theta frequency was associated 
with better cognitive function. In a healthy community sample of participants, decreases in slow 
activity (7Hz), recorded using magnetoencephalography (MEG), were found in older (55-89 years 
old) compared to younger participants (18-54 years old) (Vlahou et al., 2014).  However, those 
older participants who were able to maintain relatively high levels of slow activity tended to 
perform better in working memory and executive function tasks than those with decreased slow 
activity (Vlahou et al., 2014). In a similar study methodology with 73 healthy older adults, 
increased theta frequency power in frontal and parietal midline electrodes was associated with 
better performance in verbal memory, executive function and attention tasks (Finnigan and 
Robertson, 2011).  This study formed the basis for Finnigan et al.’s (2011) theta frequency and 
alpha slowing theory. 
 
Alpha slowing 
As outlined above it is postulated that the significant relationships between posterior power in the 
classical upper theta frequency range and cognitive impairment found in the current study are, at 
least in part, due to slowed alpha frequency power. Although there were no significant correlations 
between pre-discharge alpha frequency power and cognitive impairment at 3-months post-stroke, 
there were several significant relationships across the scalp between PAF measures and outcome 
MoCA score.  PAF is a measure that indexes slowing of alpha frequency activity.  Generally the 
alpha band is the dominant frequency in the human scalp EEG with maximal posterior power 
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during eyes closed resting states, as was the condition under which recordings were undertaken in 
the current study.  The opposite is true for theta frequency activity which generally has maximal 
power during cognitive tasks (Widagdo et al., 1998, Klimesch, 1999). It can be difficult to decipher 
the difference between slowed alpha frequency activity (<7Hz) and genuine theta power during 
resting state EEG.    
 
Slowing of background alpha frequency overlying ischaemic regions following stroke indicates 
reduced cerebral blood flow and neuronal damage (Jordan, 2004).  Dubovik et al. (2013) 
investigated alpha frequency activity recorded at 3-months following ischaemic stroke in 20 
patients and in 19 healthy controls (Dubovik et al., 2013).  Cognitive domains including executive 
functioning, verbal and working memory were assessed in each patient. Functional connectivity 
assessed using a coherence measuring the alpha frequency was significantly reduced over the lesion 
affected hemisphere in stroke patients and there was a correlation between increased functional 
connectivity in the alpha frequency and better performance on the cognitive tasks.  Furthermore the 
regions of increased functional connectivity in the alpha frequency were critical for processing the 
specific cognitive function for example, good performance on verbal fluency tasks correlated with 
increased functional connectivity in Broca’s areas (left inferior frontal gyrus) (Dubovik et al., 
2013).  This study outlines the value of post-stroke alpha frequency measures in assessing cognitive 
function and supports the postulation that in the current study power in the classical theta frequency 
is actually indexing slowed alpha frequency power and is associated with post-stroke cognitive 
impairment. 
 
In future studies the use of a measure that indexes power in both alpha and theta frequencies may be 
of value.  One study used an alpha/theta ratio to screen for Alzheimer’s dementia (Schmidt et al., 
2013). In a group of 50 patients with probable Alzheimer’s dementia (MMSE scores 12-25) and 57 
healthy participants (MMSE score over 25) aged 50 years and older resting state EEG was recorded 
(Schmidt et al., 2013).  Regression analysis revealed that alpha/theta ratio in the occipital and 
central regions (O1 and C3 electrodes) were the best predictors of Alzheimer’s disease.  Although 
this study investigates the screening of Alzheimer’s disease the regions and QEEG frequencies of 
interest are shared with the current stroke study.  In future analyses the post-stroke screening value 
of an alpha/theta ratio in prognosticating post-stroke cognitive impairment could be investigated.  
 
QEEG screening model 
Although there were several significant correlations between PAF indices across the scalp and 
outcome MoCA scores they were not selected for inclusion in the regression model.  
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Centrotemporal and occipital power in the upper theta frequency range were, statistically, better 
predictors of cognitive impairment.  Using both predictors the model was able to correctly classify 
81% patients as cognitively impaired or normative.  Following on from the regression model the 
ROC curve analysis was used to define cut-off values for the two QEEG predictors.  Occipital 
relative theta frequency power greater than 0.148 µV was identified as the optimal cut-off mark to 
indicate cognitive impairment. Central relative theta frequency power greater than 0.139 µV was 
identified as the optimal cut-off mark to indicate cognitive impairment.  The area under the curve 
was significant for both measures (p≤0.05) however occipital power in the theta frequency range 
had higher levels of both sensitivity and specificity to detect cognitive impairment than in the 
centrotemporal region.  At this stage in the investigation the cut-off value of both indices have been 
identified, in any future larger scale validation studies a composite cut-off measure comprising both 
regions (relative centrotemporal and occipital power in the classical upper theta frequency range) 
would be best for clinical application. 
 
The accuracy of the pre-discharge QEEG model was compared to the accuracy of the pre-discharge 
MoCA model.  The pre-discharge MoCA model was able to correctly classify 92% of 25 patients as 
normative or cognitively impaired whereas the QEEG model was able to correctly classify 81% of 
31 patients.  Although the pre-discharge MoCA was able to classify a small proportion of patients 
more accurately than the QEEG model both were significant and importantly the latter QEEG 
model contains measures that can be obtained from all patients, whereas the pre-discharge MoCA 
assessment could not.  Of the 38 patients in total recruited for in this study, 5 (13%) could not 
complete the pre-discharge MoCA due to impairment (4 upper limb hemiparesis and 1 visual 
impairment).  This is consistent with findings of Pendlebury (2010) who reports that in a cohort of 
289 patients, 13% were unable to complete the MoCA or MMSE assessments (at 6 months post-
stroke) due to pre-existing or stroke related conditions (Pendlebury et al., 2010).   
 
QEEG measures could be used in addition to brief cognitive tests where possible and in place of 
them in patients who may otherwise go without objective testing.  EEG recording is virtually 
without contraindication and can be used in a wide variety of patients who may otherwise be 
precluded from pen and paper screening tests such as those who are non-verbal, unconscious, those 
who do not speak English and those with upper limb hemiparesis.  In addition EEG is relatively 
inexpensive in comparison to other imaging modalities such as MRI.  EEG recording machines are 
portable and can be used at bedside with little disturbance to the patient.  The results of this 
regression analysis suggest that less than 3 minutes of EEG recorded from just 2 occipital and 4 
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central electrodes is all that is needed to offer a comparatively accurate post-stroke cognitive 
screening measure to those currently used in clinical assessments (such as the MoCA). 
 
Limitations 
There were several demographic factors which may influence the results of the current study. 
Firstly the sample was made up of patients from a wide range of ages; it would be valuable to assess 
these measures particularly the relative theta frequency cut-off values identified in the ROC curve 
in older and younger samples.  Changes to alpha power occur across the lifespan with a general 
pattern of slowing with age (Klimesch, 1999).  Assessing these measures in older and younger 
stroke patients would help define whether age affected the theta frequency power cut-off score to 
classify cognitive impairment and whether more accurate analyses could be developed for older and 
younger patients.   
 
Secondly there were more males (n=21) than females (n=10) in the study sample.  This bias may be 
reflective of the population as males are more likely to suffer from a stroke than females (The 
economic impact of stroke in Australia, 2013). In addition there was a greater number of patients 
with right hemisphere stroke than left. It is possible that the sample bias toward patients with right 
hemisphere strokes was due to the influence of language impairments in those with left hemisphere 
stroke. Communication difficulties and the ability to give consent to participate in the study may 
have effected recruitment rates of those with left compared to right hemisphere stroke.  It is 
important to note however, that the method used to calculate QEEG indices across regions, is not 
lateralised, and in therefore likely to accommodate any bias towards right handed stroke.  
 
This study focused on MCA territory ischaemic stroke.  It would be interesting if future studies 
could investigate the relationships between pre-discharge QEEG indices and cognitive outcomes in 
other vascular territories and haemorrhagic stroke types to determine whether QEEG may be useful 
in classifying cognitive impairment in those cases also.    
 
The MoCA was used as the outcome measure to assess cognitive impairment.  Although past 
studies show that the MoCA is accurate for detecting post-stroke cognitive impairment it is only a 
screening measure (Arciniegas et al., 2011, Dong et al., 2012).  In future more detailed cognitive 
assessments investigating multiple domains could be adopted to accurately investigate how specific 
domains relate to the QEEG measures.  This was not feasible in this study as there were insufficient 
funds to employ a registered clinical neuropsychologist to administer such assessments. 
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Lastly it is important to take into consideration that multiple comparisons were made without using 
a corrective measure such as the Bonferonni correction.  As outlined in the methods section the 
widely referenced Perneger (1998) statistical journal article outlines the limited value of such 
corrections and advises instead the use of careful explanation of results and limitations (Perneger, 
1998).  As this is the first study that assesses the value of QEEG indices in predicting post-stroke 
cognitive impairment it appears valid to consider results which otherwise would be overlooked due 
to a correction technique which may well be overly stringent. 
 
Conclusion 
Pre-discharge QEEG indices may be useful indicators of subsequent cognitive outcome in MCA 
territory ischaemic stroke.  Relative power in the classical upper theta frequency range and PAF 
were identified as the most informative measures of post-stroke cognitive impairment particularly in 
the posterior regions of the scalp.  These results support the postulation that these QEEG measures 
reflect alpha slowing, and that increased alpha slowing is indicative of post-stroke cognitive 
impairment. Occipital and centrotemporal power in the upper theta frequency range were identified 
as the optimal indices to screen for cognitive impairment following stroke and were able to classify 
81% of patients accurately.   QEEG measures can be obtained virtually without contraindication in 
contrast to the commonly used pen and paper tests such as the MoCA.  This study provides the 
preliminary results to support the value of a large scale study to validate the use of pre-discharge 
QEEG indices to prognosticate post-stroke cognitive impairment. 
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CHAPTER 4 
INVESTIGATING THE RELATIONSHIP BETWEEN QEEG INDICES AND POST-
STROKE DEPRESSION 
 
4.1 Abstract 
In the previous chapters QEEG indices were linked to post-stroke cognitive impairment and 
proposed as a possible screening tool for same. At this point it is unresolved as to whether or not 
QEEG indices are associated with, or may help screen for PSD. The primary aim of the study was 
to assess the relationships between post-stroke depression (PSD) and pre (hospital)-discharge 
QEEG indices and to assess the ability of the QEEG measures to predict PSD incidence.  PSD is 
common following stroke and thought to be associated with cognitive impairment, it is therefore of 
interest to investigate the relationships between QEEG indices assessed in the previous two studies 
and PSD. This study comprises data from 38 patients; data from 4 of these patients were included 
Chapter 2, data from the remaining 32 patients included in the study are previously reported in 
Chapter 3. 
 
Pre-discharge assessments including EEG recording, Montreal Cognitive Assessment (MoCA), 
National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) were carried 
out at median 95 hours post-stroke symptom onset (range: 48-239 hours).  Outcome assessments 
including Geriatric Depression Scale (GDS), MoCA, NIHSS, mRS and Functional Independence 
Functional Assessment measure (FIM-FAM) were carried out at median 101 days post stroke 
(range: 69-138 days). Relative power for delta, theta, alpha, beta and delta:alpha ratio (DAR) were 
calculated and averaged across regional planes of electrodes.  Brain symmetry index (BSI), delta 
BSI and alpha BSI for homologous pairs of electrodes were also calculated.  GDS scores were 
correlated with QEEG indices using Spearman's coefficient. Binary logistic regression was used to 
build a QEEG screening model to classify PSD. GDS scores ≥6 out of 15 were classified as 
depressed. 
 
Thirty-one participants with MCA territory, ischaemic stroke (11 female, age range: 18-87) were 
included in the study.  GDS scores were significantly correlated with gender, females tended to 
have higher scores than males indicating more depressive symptoms (r=-0.475, p=0.007, n=31).  
GDS outcome scores were also correlated with delta BSI between posterior temporal electrodes (r=-
0.378, p=0.036, n=31); patients with more symmetric delta power (at T5-T6) tended to have higher 
GDS scores.  Delta BSI (T5-T6) was selected as a potential predictor variable in the regression 
model to predict PSD, however, it did not significantly contribute to the prediction model.   
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These results indicate that although there is an association between PSD and delta BSI (T5-T6) it 
does not statistically improve the accuracy of identifying which patient will or won’t develop 
subsequent PSD. 
 
4.2 Introduction 
Post-stroke depression (PSD) is characterised by persistent depressed mood resulting from the 
physiological effects of stroke (Godefroy, 2007).  PSD is relatively common, at 3-months post-
stroke, one third (33%) of 1,101 stroke patients screened positive for PSD using the Hospital 
Anxiety and Depression Scale (HADS) (Ayerbe et al., 2013).  In addition the proportion of patients 
with depression remained relatively stable, at approximately 30%, during the study’s 15-year 
follow-up period (Ayerbe et al., 2013).  Following stroke, patients with depressed mood are more 
likely to have severe disability at 6-24 months (Willey et al., 2010) and an increased risk of death 
(Ellis et al., 2010) and cognitive impairment (Kauhanen et al., 1999).  It is imperative that PSD is 
detected early following stroke so that it can be most effectively managed. This in turn should help 
the aforementioned unfavourable sequelae associated with depression. 
 
There are several pen and paper assessments commonly used to assess PSD.  The geriatric 
depression scale (GDS) (Yesavage et al., 1982, Javaid I. Sheikh, 1986) is based on self-report and 
was developed to assess depression in elderly populations, there are both long (30 items) and short 
versions (15 items) of the assessment.  Although the scale is well suited to assess PSD in 
comparison to other short depression scales (Agrell and Dehlin, 1989, Tang et al., 2004), self-rating 
assessments are not optimal in patients with high instances of associated cognitive impairment, as 
are found in stroke populations.  In addition, responses to the wording of items from the GDS such 
as: ‘Have you dropped off many of your activities and interests?’ (over the past week), may not be 
related to loss of interest or motivation but more so to the impact of functional impairment and 
disability as a result of stroke.  QEEG recording is a method that overcomes the limitations and 
subjectivity of self-report assessments and QEEG indices may provide insight into which patients 
may have/or develop PSD.  QEEG is virtually without contraindication, it can be administered at 
bedside and it does not require the patient to actively respond or participate in testing as pen and 
paper tests do. 
 
In previous chapters QEEG indices have been linked to post-stroke cognitive impairment and 
proposed as a possible screening tool for same. At this point it is unresolved as to whether or not 
QEEG indices are associated with, or may help screen for PSD. A relationship between QEEG delta 
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frequency power and depression has been shown in a non-stroke population (Morgan et al., 2005).  
EEG was recorded in 76 participants diagnosed with depression using DSM-IV criteria and 28 
healthy control participants.  A significant increase in slow delta frequency power was observed in 
depressed versus non-depressed subjects.  However the study also analysed other factors that may 
affect QEEG indices and found the higher delta power was greater in patients with other 
impairments such as dementia (Morgan et al., 2005).  Similar results involving delta frequency 
power and depression in a stroke population were reported in a recent study.  Forty-three stroke 
patients were included; of those 21 had PSD (identified using DSM-IV criteria at the time of EEG 
recording) (Zhang et al., 2015).  EEG was recorded within a year of stroke (using 16 electrodes 
following the 10-20 international system).  Patients with PSD were found to have significantly 
greater delta power in frontal and central electrodes and greater alpha frequency power in frontal 
and right temporal regions (Zhang et al., 2015). These studies suggest that delta frequency power 
may be a measure of interest when assessing PSD. 
 
Brain symmetry index (BSI) has been found to be informative for prediction of stroke outcomes for 
example, death and disability/dependence. (van Putten and Tavy, 2004, Sheorajpanday et al., 2011).  
In addition to changes in delta power, depression has been associated, in some studies of non-stroke 
patients, with a lower alpha power in the right and higher alpha power in the left hemisphere 
(Olbrich and Arns, 2013).  Resting state EEG was recorded in 20 females with depression and 40 
matched healthy women.  Increased right frontal alpha power was seen in participants with 
depression compared to the healthy participants (Chang et al., 2012). Lower alpha power in the 
right hemisphere may be associated with depression however findings have been inconsistent 
possibly due to the fact that gender, other mood disorders such as anxiety and age and handedness 
may impact alpha activity in these regions also (Morgan et al., 2005, Stewart et al., 2011). 
 
Cognitive impairment is a main risk factor for depression at 1-month post-stroke (Andersen et al., 
1995) and the prognosis for patients with depression and cognitive impairment is worse than that of 
patients with depression only (Downhill and Robinson, 1994).  There are many studies that show 
significant associations between PSD and cognitive function (Downhill and Robinson, 1994, 
Spalletta et al., 2002, Arauz et al., 2014).  In addition to cognitive impairment there are links 
between PSD and functional impairments.  A recent review assessed 15 studies that investigated 
functional impairment and disability in PSD, in all but one study increased impairment was a risk 
factor for PSD (De Ryck et al., 2014a).  The current literature suggests an association between PSD 
and increased levels of both cognitive and functional impairment. Early and effective screening of 
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PSD is vital so that it can be effectively treated and monitored.  This is especially important prior to 
rehabilitation so that measures can be taken to encourage maximal participation and goal planning.  
 
Analyses reported in this chapter will investigate potential associations between pre-discharge 
QEEG indices and outcome depression measures as well as the ability of QEEG to inform 
prognostication of depression outcomes.  In addition to the QEEG indices assessed in Chapter 3, 
interhemispheric brain symmetry, assessed using the brain symmetry index (BSI) will be included 
in the analyses. Given past results cited above, BSI will be analysed across 3 frequencies (1-25 Hz, 
alpha and delta).  
 
Finally, potential relationships between PSD and other outcome scales’ measures will also be 
analysed, as will the efficacy of standard clinical scales (such as the National Institute of Health 
Stroke Scale and modified Rankin Scale) administered pre-discharge to inform prediction of PSD. 
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4.3 Methods 
Patients 
Approval to carry out the study was obtained from the local University and Hospital Human 
Research Ethics Committees. Written informed consent from each patient or substitute decision 
maker was obtained. Patients were recruited from the Royal Brisbane and Women’s Hospital acute 
stroke unit between December 2012 and July 2015.  Patients who were under the age of 18 years or 
pregnant were excluded from participating in the study.  All patients underwent acute non-contrast 
computed tomography (NCCT) scanning and the majority of cases also had CT perfusion scanning.  
When clinically required, patients underwent additional magnetic resonance imaging (MRI). 
Patients with radiologically confirmed middle cerebral artery (MCA) territory ischaemic stroke 
were included in this analysis.  Time and date of stroke was documented by the time of symptom 
onset.  In cases of wake-up strokes, time of onset was documented as the mid-point between time to 
bed (no symptoms) and time of wake-up (with symptoms). 
 
Pre-discharge EEG  
Eyes closed resting state EEG was recorded at bedside in the acute stroke unit before discharge 
within 10 days of stroke symptom onset and as close as feasible to 72 hours.  EEG was recorded 
using a NicOne Brain Monitor system (Natus Medical Inc.) with a sampling rate of 500 Hz. 
Nineteen Ag/Ag–Cl electrodes (Nicolet) were applied according to the International 10–20 system 
(Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4, T5, T6, Fz, Cz, Pz).  Electrode 
impendences were primarily between 5–10 kΩ or less.  EEG was recorded for approximately 10-15 
minutes and alertness/sleepiness was assessed behaviourally intermittently throughout the duration 
of the recordings. 
 
Depression, cognition and functional assessments 
Pre-discharge assessments were carried out on the same day as the EEG recording.  Outcome 
assessments were carried out at approximately 3-months post-stroke.  Each of the following 
measures was assessed at both pre-discharge and outcome: stroke severity using the National 
Institute of Health Stroke Scale (NIHSS); disability using the modified Rankin Scale (mRS); 
cognitive function using the Montreal Cognitive Assessment (MoCA).  
 
Independence in carrying out activities of daily living was assessed using the Functional 
Independence-Functional Assessment Measure (FIM-FAM), assessed only at 3-months post-stroke.  
The FIM-FAM is a 30 item test assessing self-care, toileting, transfers, mobility, social interaction, 
communication and cognitive function.  A sub-scale of the cognitive items on the scale (FIM-
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FAMcog) was used to assess functional cognitive impairment and assess problem solving, memory, 
safety judgement, attention and orientation.  Tasks are scored on a scale of 1-7 with 1 indicating full 
dependence and 7 indicating full independence in carrying out the activity.  Depression was 
assessed at 3-months post-stroke using the Geriatric Depression Scale (GDS).  It is a self-report 
measure with responses indicated as yes or no, the 15-item version of the GDS was employed.  A 
score of ≥6 is considered an indication of depressed mood (Yesavage et al., 1982, Javaid I. Sheikh, 
1986). 
 
EEG analysis 
EEG signal processing and analysis was performed offline using Curry Neuroimaging Suite 7.0.8 
(Compumedics Neuroscan).  For each participant EEG recordings were filtered (lowpass 35Hz 
Slope 8Hz, in cases with excessive noise a 50Hz notch filter was also used) and segmented into 
4096ms duration epochs, baseline corrected and referenced to Cz. The first 45 epochs (3 minutes) 
of clean EEG were selected and averaged.  The Fast Fourier transform was used to calculate the 
power spectra which resulted in a value for each 0.12Hz iteration at each electrode. 
 
Absolute power was summed across the delta (0.98–3.91 Hz), theta (4.15–7.57 Hz), alpha (7.81–
12.45 Hz) and beta (12.70–30.03 Hz) bands (inclusive).  For each electrode the following analyses 
were then calculated from these raw values; relative delta, theta, alpha and beta power and 
delta:alpha ratio (DAR).  DAR and relative power was averaged for each frequency measure across 
frontal polar (Fp1-Fp2), frontal (F7-F3-Fz-F4-F8), centrotemporal (T3-C3-C4-T4), parietotemporal 
(T5-P3-Pz-P4-T6) and occipital regions (O1-O2) (Figure 1.) 
 
The brain symmetry index (BSI)  (Sheorajpanday et al., 2009) was calculated across the 1-25Hz 
frequency range as is standard.  In addition BSI was calculated specifically for the alpha frequency 
(7.81-12.45Hz) and the delta frequency (0.98-3.91Hz) ranges.  BSI for each frequency range was 
calculated across 8 pairs of homologous electrodes referenced to the common average reference 
(CAR) as per methodology in Sheorajpanday et al. (2009) (Fp1–Fp2; F3–F4; C3–C4; P3–P4; O1–
O2; F7–F8; T3–T4; T5–T6). BSI-indexing interhemispheric amplitude (a)symmetries in individual 
electrode pairs were calculated as follows: 
For example, Fp1-Fp2 BSI=   
The direction of raw BSI calculations indicate the laterality of the asymmetry (for example, greater 
right hemisphere power indicated by positive values and greater left hemisphere indicated by 
negative values). In the current study the degree of asymmetry for each electrode pair was of 
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interest, therefore the absolute values of each electrode pair BSI calculation rather than raw values 
are reported to indicate degree of asymmetry regardless of laterality. 
 
Statistical Analysis 
All data were analysed by SPSS (IBM SPSS Statistics, Version 22). Spearman correlation 
coefficients were analysed to identify relationships between GDS scores and pre-discharge QEEG 
indices, MoCA, NIHSS and mRS scores.  Point-biserial correlation analysis was used to investigate 
the relationship between GDS score and gender.  Correlations between GDS score and outcome 
measures the MoCA, FIMFAM, NIHSS and mRS were also assessed.  Any correlations with 
p≤0.05 were considered significant; correction for multiple comparisons was not used according to 
Perneger (1998).  Perneger outlines the limited value of corrections for multiple comparisons (such 
as the Bonferroni correction) and advises instead the use of careful explanation of results and 
limitations (Perneger, 1998) 
 
Binary logistic regression was used to build a model using QEEG indices to screen for PSD.   
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4.4 Results 
Thirty-eight patients were recruited of which 1 was excluded due to prominent bilateral infarction, 2 
were excluded as outliers based on their documented excessive alcohol use (and data) and 4 
participants were unable to attend the follow-up assessment.  The remaining 31 participants (11 
female, median age: 69, range: 18-87) were included in the subsequent analyses, demographic 
information including stroke severity and MoCA scores are documented in Table 1.   
 
Pre-discharge assessments including EEG recording, MoCA, NIHSS and mRS were carried out at 
median 95 hours post stroke symptom onset (range 48-239 hours).  Outcome assessments including 
GDS, MoCA, NIHSS, mRS and FIM-FAM were carried out at median 101 days post stroke (range 
69-138 days).   
 
PSD was classified using GDS scores. Patients with scores ≥6 were considered to have PSD and 
those with scores ≤5 were considered not to have PSD (Javaid I. Sheikh, 1986).  Nine of 31 patients 
(29%) classified as PSD at outcome and 17 out of 31 (55%) screened positive for pre-discharge 
cognitive impairment (MoCA score ≤25). 
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ID 
Stroke 
Territory 
Age Gender 
MoCA 
(pre-
discharge) 
MoCA 
(outcome) 
NIHSS 
 (pre-
discharge) 
NIHSS 
(outcome) 
mRS   
(pre-
discharge) 
mRS 
(outcome) 
GDS 
(outcome) 
1 R MCA 77 M 26 26 3 1 1 1 1 
2L L MCA 84 M 15 21 1 0 1 0 0 
3 L MCA 47 M 13 22 3 0 2 0 0 
4L R MCA 72 M 20 23 10 1 4 1 2 
5 L MCA 61 F 26 NA 0 NA 0 0 13 
6W L MCA 78 F 25 24 0 0 0 0 0 
7 L MCA 74 M NA 22 3 0 1 2 3 
8L, W L MCA 54 M 28 30 0 0 0 0 1 
9 L MCA 65 M 26 29 1 0 1 0 2 
10 R MCA 80 M NA NA 3 0 2 1 1 
11W L MCA 87 F 16 NA 5 NA 4 3 7 
12 L MCA 76 M NA NA 4 NA 3 3 2 
13 R MCA 18 F 28 30 0 0 1 1 8 
14 L MCA 61 M 24 27 0 0 2 0 0 
15 R MCA 72 F 21 21 1 0 1 2 10 
16L R MCA 52 M NA 27 21 13 5 4 9 
17L R MCA 66 M 22 28 7 3 4 3 1 
18 R MCA 67 M 18 24 5 1 3 2 6 
19W R MCA 71 F 11 25 2 1 3 0 2 
20W R MCA 61 F 25 28 4 1 3 1 2 
21W R MCA 78 F 15 20 19 7 5 3 5 
22 R MCA 69 F 27 27 0 1 1 1 8 
23 R MCA 74 M 23 25 0 1 1 2 7 
24 R MCA 66 M 23 23 0 0 0 1 5 
25W L MCA 67 M 28 29 0 0 0 0 0 
26W R MCA 81 F 18 23 1 0 2 1 2 
27 R MCA 46 M 29 29 0 0 0 0 2 
28W R MCA 69 M 24 27 1 0 1 0 0 
29W R MCA 57 M 26 26 1 0 1 0 2 
30WL R MCA 72 F 15 14 2 1 3 2 7 
31 R MCA 69 M 26 27 0 0 2 0 0 
Table 1. Patient demographics and stroke details 
R MCA: Right middle cerebral artery, L MCA: Left middle cerebral artery 
L: Patient was received tissue plasminogen activator (rtPA) W: Patient had wake-up stroke 
 
Spearman Correlation Analysis: Pre-Discharge measures and GDS 
GDS score did not significantly correlate with pre-discharge measures of stroke symptom severity 
(NIHSS), disability (mRS) or cognitive impairment (MoCA). GDS score did however significantly 
correlate with gender, females tended to have higher scores than males indicating more depressive 
symptoms (r=-0.475, p=0.007, n=31).  The only significant correlation between pre-discharge 
QEEG and outcome GDS score was for delta BSI between T5-T6 electrodes (r=-0.378, p=0.036, 
n=31), patients with more symmetric delta power (lower BSI) at posterior temporal electrodes 
tended to have greater degrees of depression (higher GDS scores) (Figure 1).   
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Figure 1. Scatterplot of GDS score and delta BSI in T5-T6 electrodes 
 
Spearman Correlation Analysis: Outcome measures and GDS 
Outcome GDS scores were significantly associated with outcome FIM-FAM total scores (r=-0.667, 
p≤0.001, n=31) and with the FIM-FAMcog scores (r=-0.567, p=0.001, n=31).  These results 
indicate that patients who were more independent in their activities of daily living tended to be less 
depressed.  GDS was also associated with outcome mRS (r=0.582, p=0.001, n=31) and outcome 
NIHSS (measure of stroke symptom severity) (r=0.432, p=0.022, n=28).  These results show that 
patients with greater stroke severity and disability tended to have greater levels of depression (see 
Table 2). 
 
Time of assessment Variable name Correlation statistics with outcome MoCA score 
Pre-discharge 
variables 
Gender r=-0.475* 
Delta BSI T5-T6 r=-0.378* 
Outcome variables 
FIM-FAM r=-0.667** 
FIM-FAMcog r=-0.567** 
mRS r=0.582** 
NIHSS r=0.432* 
 
Table 2. Correlation table including Spearman correlation coefficients for all significant correlations between outcome 
GDS scores and pre-discharge and outcome variables 
*p≤0.05, **p≤0.001 
 
Binary Logistic Regression Analysis 
A logistic regression analysis was carried out to analyse the ability of QEEG indices to predict PSD.  
PSD was again classified using GDS, with scores ≥6 indicating PSD (Javaid I. Sheikh, 1986).  The 
results of correlation analysis were used to build the binary logistic regression model.  Delta BSI 
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(T5-T6) was identified as the only QEEG measure that significantly (p≤0.05) correlated with GDS 
score.  Thus delta BSI (T5-T6) was entered as the sole predictor variable in the QEEG model.   
 
A test of the QEEG model against the constant only model was not significant; indicating that pre-
discharge delta BSI (T5-T6) was unable to reliably distinguish between the presence or absence of 
subsequent PSD as measured by the GDS. The test of model coefficients indicates that the addition 
of temporal delta BSI did not significantly contribute to the accuracy of the model (see Table 3). 
 
Independent Variables b OR (95% CI) Significance 
Delta BSI (T5-T6)  -5.339 0.005 (0.000-8.416) 0.61 
χ2(1)=2.602, p≥0.05 
Table 3. Coefficients of the QEEG model predicting PSD 
OR: odds ratio, b: Beta value 
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4.6 Discussion 
The incidence of PSD as classified by the GDS was 29%; this is in close agreement with incidence 
reported in several PSD studies (Ayerbe et al., 2013, De Ryck et al., 2014b). Delta BSI (across the 
T5-T6 electrode pair) was the only QEEG measure that had a significant correlation with GDS 
scores.  It was found that those with greater interhemispheric delta symmetry (T5-T6) tended to 
have higher levels of depression.  Gender was also significantly associated with GDS scores; 
women tended to have higher levels of PSD than men.  No other pre-discharge variable - including 
disability, stroke severity or cognitive function - were significantly associated with PSD at 3-
months post-stroke.  None of the pre-discharge measures (including QEEG indices) were able to 
reliably predict depression at 3-months post-stroke using binary logistic regression modelling.   
 
GDS scores were associated with concomitant outcome disability (mRS) and stroke severity 
(NIHSS) scores; patients with greater disability and stroke severity tended to have higher levels of 
depression.  GDS scores were also significantly related to functional independence at 3-months 
post-stroke (and FIM-FAMcog), with greater degrees of dependence related to a higher number of 
depressive symptoms.  However GDS scores were not associated with concomitant cognitive 
functions measured by the MoCA. 
 
Delta power and depression 
Delta power was identified as a frequency of interest in relation to PSD in a recent study.  Zhang et 
al. (2015) assessed and compared QEEG indices in 3 groups including: healthy controls (n=15), 
post-stroke depression (PSD) patients (n=21) and post-stroke no depression patients (n=22) 
classified using DSM-IV criteria.  PSD patients had significantly greater absolute delta power (0.5-
4Hz) in electrodes across all brain regions than the healthy controls and/or the post-stroke no 
depression patients (Zhang et al., 2015).  Although delta BSI was not assessed in the study they did 
include a histogram comparing absolute delta power across 16 electrodes averaged for each of the 
three sample groups.  Based on visual inspection PSD patients had a larger absoluter delta power in 
T5-T6 electrodes than the post-stroke no depression patients and the healthy controls (both had very 
similar levels). There was very little difference apparent between delta power in the T5 compared to 
T6 electrodes in the PSD group which indicates general symmetry between the left and right 
hemisphere in this group.  This result is broadly consistent - albeit an averaged finding across the 
PSD group compared to the individual results analysed in the current study - with the findings of 
the current study where greater T5-T6 delta symmetry was associated with higher GDS scores. 
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In the current study greater interhemispheric delta symmetry in temporal electrodes was associated 
with greater levels of depression.  It should be noted that in Zhang et al. (2015) there was no 
apparent difference in the levels of asymmetry between patients with PSD and the healthy control 
group or the post-stroke no depression patients. There may be several reasons for the discrepancy in 
the level of asymmetry seen in patients with depression and without between the current study and 
Zhang et al. (2015).  Firstly they did not calculate specific BSI indices across electrode pairs as was 
done in the current study; the interpretation is based on visual comparison of absolute delta power 
plotted in a histogram for each electrode in group average data.  In addition Zhang et al. (2015) 
report EEG recordings carried out at an average of 5 months post-stroke whereas the current study 
assessed EEG recorded within 10 days of stroke.  Although delta power may be associated with 
PSD the pattern of  the relationship  is likely to be dependent on the time of the EEG recording 
 
It is possible that the relationship between delta BSI (T5-T6) and GDS scores is due to the influence 
of greater stroke severity.  At the time of the pre-discharge EEG recording, oedema as a result of 
large and severe stroke can cause an increase in contralateral (in addition to ipsilateral) delta 
frequency power. As discussed by Finnigan et al. (2008), contralateral delta power is indicative of 
substantial worsening of pathophysiology (Finnigan et al., 2008).  Thus, greater delta frequency 
power is recorded in contralateral (as well as ipsilateral) hemispheres leading to greater symmetry 
in more severe strokes and worse associated outcomes, such as levels of PSD.  In summary greater 
degrees of delta symmetry across temporal electrodes (T5-T6) may be indicative of stroke severity 
which is in turn associated with higher risk of PSD. Therefore based on this theory, the correlation 
between this delta BSI measure and GDS would be largely due to delta being more symmetrical 
(and outcome GDS scores higher) in more severe strokes. 
 
Finally both age and gender can impact QEEG indices. EEG was recorded in 104 non-stroke 
participants; depression was diagnosed in 76 patients using DSM-IV criteria (Morgan et al., 2005).  
It was found that depressed participants had significantly higher absolute delta frequency power 
than non-depressed participants and that in both groups age was significantly correlated with delta 
power.  In addition females tended to have higher levels of absolute delta power than males 
independent of depression severity as measured using the Hamilton Depression Rating Scale 
(HDRS) (Morgan et al., 2005).  Gender was found to be associated with GDS score in the current 
study with females tending to have greater scores than males.  In a recent systematic review of risk 
factors associated with PSD, gender was assessed in 21 of the analysed studies (De Ryck et al., 
2014a).  Of the 8 studies that found a significant relationship between gender and PSD, 7 indicated 
that females have a greater risk of PSD (De Ryck et al., 2014a).  Differences in gender and age 
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ranges of the sample populations may affect the power of various QEEG indices especially delta 
power.  This may suggest why interhemispheric delta symmetry (T5-T6) was not a reliable 
indicator of PSD, it is too easily influence by other non-depression related factors. 
 
Posterior versus frontal activity 
The current study revealed novel results in regards to the location of the delta BSI associated with 
GDS scores.  Typically (non-stroke) depression studies focus primarily on frontal asymmetry 
(Mumtaz et al., 2015). No frontal QEEG measures in this study were significantly associated with 
outcome GDS scores.  However, as was found in the current study with temporal indices, Fernandez 
et al. (2005) hypothesised that frontal brain regions would be of primary interest in their study of 
depression, whereas posterior measures were instead significantly associated with depression. They 
used magnetoencephalography (MEG) to investigate delta and theta power measures (using dipole 
density) in 31 depressed patients (DSM-IV criteria) and 22 healthy controls (Fernandez et al., 
2005).  As with the current study only measures of delta frequency activity in posterior electrodes 
(right occipital and left temporal electrodes) were associated with depression.  
 
PSD regression model 
The QEEG based binary logistic regression model was not able to accurately screen for PSD that is, 
no QEEG variables were able to contribute significantly to an accurate model (despite pre-discharge 
delta BSI in T5-T6 being significantly correlated with outcome GDS scores).  Similar results were 
found in studies investigating alpha symmetry and PSD.  Davidson (1998) reports that although 
there are associations between EEG recorded alpha asymmetry and PSD it is not a suitable measure 
for diagnostic purposes (Davidson, 1998).  As asserted by Olbrich et al. (2013) one of the main 
reasons for those findings was the overlap in alpha asymmetry measures between groups with 
without PSD.  Similar overlap can be seen in the current study in Figure 1. The scatter plot shows a 
negative relationship between GDS scores and delta BSI in T5-T6, however there is noticeable 
overlap in delta asymmetry between patients with GDS scores ≥6, indicating PSD, and those with 
GDS scores ≤6 (indicating no PSD).  In addition the patients with PSD appear to be driving the 
correlation between delta BSI (T5-T6) and GDS scores, with delta BSI (T5-T6) <0.3 in every PSD 
patient.  Whereas those patients who are not considered to have PSD have a wide range of delta BSI 
(T5-T6) scores ranging from ~0-0.6. This may suggest that BSI is only informative of GDS 
scores/depression symptom severity in those patients with PSD. In summary, despite the significant 
correlation between delta BSI (T5-T6) and GDS scores, it is not a reliable or accurate measure of 
subsequent PSD. 
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Depression and other clinical assessment measures 
GDS scores at 3-months post-stroke were not significantly related to pre-discharge assessments of 
cognitive function, depression severity or disability.   This suggests that routinely used clinical pre-
discharge measures are not highly informative regarding PSD.  Similar results were found by Berg 
et al. (2003); neither age, gender, neurological stroke severity score nor cognitive function (assessed 
at 2 weeks post-stroke) were reliably able to predict depression (measured using the Beck 
Depression Inventory and the Hamilton Rating Scale for Depression) at 6 months post-stroke (Berg 
et al., 2003).   
 
However in the current study, higher outcome GDS scores were generally associated with the 
higher FIM-FAM, NIHSS and mRS assessed on the same day.  This suggests that less functional 
independence and greater stroke symptom severity and disability are all significantly and positively 
associated with increased depressive symptoms.  
 
Limitations 
It is important to note that in this study the GDS was used to indicate PSD.  This scale is widely 
used and validated (Yesavage et al., 1982, Javaid I. Sheikh, 1986), however it cannot replace a 
diagnoses of depression.  Instead it is best used as a screening scale that can indicate severity of 
depressive symptoms that would require further assessment using the official DSM-IV criteria, by a 
clinical psychologist.  The current study did not have the funding to employ a clinical psychologist 
to carry-out these assessments. 
 
A correction for multiple comparisons, such as the Bonferroni correction, was not used in the 
correlation analysis in the current study.  It is possible that the significant relationship between GDS 
scores and delta BSI (T5-T6) was due to type 1 error (false positive result). In addition the sample 
size of the current study was relatively small.  Taking into consideration these limitations, future 
studies could use the findings of the current study to guide investigations between QEEG indices 
and PSD in a larger sample with greater statistical power and possibly the use of more stringent 
corrections such as the Bonferroni.   
 
Lastly in future analyses it would be of value to assess PSD pre-discharge as well as at 3-months 
post-stroke. This would help decipher how pre-discharge QEEG indices relate to current level of 
depressive symptoms.  If a pattern or relationship was found this could be used as an additional 
screening measure and in cases where depression cannot be assessed otherwise such as in patients 
who cannot speak English or are aphasic.  
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Conclusion 
Bother gender and pre-discharge delta BSI (in T5-T6 electrodes) were significantly associated with 
dichotomised GDS score at 3 months post-stroke.  Female gender and relatively greater delta 
symmetry were generally associated with greater measures of depressive symptoms.  Despite the 
significant association between delta BSI and GDS scores, no pre-discharge QEEG indices were 
able to accurately predict the presence of PSD via regression analysis. 
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
This research investigated the relationship between various post-stroke QEEG indices and outcome 
measures including cognitive and functional impairment and post-stroke depression (PSD).  In 
addition the potential ability of QEEG indices to screen for and prognosticate those conditions were 
analysed.  The results of these studies have the potential to improve the early screening of cognitive 
impairment (and possibly PSD), particularly in patients unable to complete standard pen and paper 
cognitive screening.  Improved early screening of post-stroke impairments can lead to better 
informed pre-discharge decisions regarding patient management, treatment and rehabilitation and in 
turn improved outcomes for patients and the community. 
 
In the first study (Chapter 2), it was established that two QEEG measures both sensitive to alpha 
frequency power were associated with general functional and cognitive outcomes assessed using the 
FIM-FAM and FIM-FAM cognitive subscale (FIM-FAMcog).  Higher alpha frequency power 
across the scalp and increased slow relative to fast activity in frontal regions (DAR) were associated 
with worse general cognitive and functional outcome.  Following this initial study, the value of 
QEEG measures in prognosticating cognitive impairment were assessed in more detail using the 
MoCA (Chapter 3).  Slowing of alpha frequency activity - indexed by both peak alpha frequency 
(PAF) and increased power in the upper theta frequency (particularly across the posterior regions of 
the brain) - was associated with lower MoCA scores and cognitive impairment.  Using regression 
analysis measures of posterior, slowed alpha activity were able to accurately predict cognitive 
impairment in 81% of participants.  The final study investigated the potential for QEEG measures to 
screen for PSD (Chapter 4).  Although increased symmetry across left and right temporal regions in 
the delta frequency was correlated with increased GDS scores and PSD symptoms, it was not found 
to be an accurate measure to prognosticate PSD outcome using regression modelling. 
 
QEEG correlations with functional and cognitive outcome measures (Chapter 2) 
The FIM-FAM was used in Chapter 2 to assess post-stroke outcomes regarding both overall 
functional independence and that relating to cognitive outcome function.  The FIM-FAM is a 30-
item measure designed to primarily assess a patient’s functional independence in their activities of 
daily living (ADL).  It is commonly used in rehabilitation to monitor functional independence 
throughout the program.  The FIM-FAM is scored on a 7 point scale ranging from total dependence 
to total independence in carrying out ADL’s in categories including mobility, self-care, 
communication, locomotion and cognitive function.  In Chapter 2 we assessed the relationships 
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between QEEG indices with both the full 30-item FIM-FAM scale and a sub-scale of 5 cognitive 
items (FIM-FAMcog).  The cognitive items assess problem solving, memory, orientation, attention 
and safety judgment.  Although the FIM-FAMcog is not a dedicated cognitive assessment as such, 
this sub-scale has been used to measure cognitive function in a study that investigated post-stroke 
rehabilitation (Leon-Carrion et al., 2009) and another that assessed risk-factors and incidence of 
PSD (De Ryck et al., 2014b). 
 
Before the correction for multiple comparisons was applied relative delta and alpha frequency 
power and DAR across frontal (F3, F4, F7, F8) and posterior (P3, P4, T5, T6) electrodes were 
associated with both general functional outcome as well as the FIM-FAMcog.  Common average 
referencing (CAR) was used, as it is in previous stroke studies assessing similar QEEG measures 
(Sheorajpanday et al., 2009, Sheorajpanday et al., 2010, Sheorajpanday et al., 2014).  The results of 
this initial analysis showed that lower global relative power in the alpha frequency band was 
associated with higher levels of cognitive impairment (lower FIM-FAMcog scores) at follow-up.  
The DAR, indexing the ratio of slower delta to faster alpha frequency activity (a measure of QEEG 
slowing) was also negatively correlated with FIM-FAMcog.  Notably this was only significant for 
the frontal DAR; greater levels of frontal slowing were associated with greater levels of cognitive 
impairment.   
 
Prognosticating cognitive impairment with QEEG indices (Chapter 3) 
In the following study (Chapter 3) the MoCA was adopted to more systematically assess cognitive 
function across multiple domains.  In contrast to the FIM-FAM the MoCA was developed to 
specifically assess cognitive function (Nasreddine et al., 2005).  In addition to memory, attention 
and orientation assessed more generally in the FIM-FAMcog, the MoCA also includes visuospatial, 
executive function and language tasks.  The MoCA has been identified in several studies as a 
reliable and suitable indicator of post-stroke cognitive impairment (Dong et al., 2010, Cumming et 
al., 2011, Pendlebury et al., 2012a, Pendlebury et al., 2012b).  In addition the MoCA has 
methodological advantage over the FIM-FAM in that scores are completely dependent on 
demonstrated completion of tasks.  The FIM-FAM, at least in part, relies on the patient accurately 
reporting their difficulties in independently completing ADL’s related to cognitive function and the 
assessor’s judgment of these reports, for example, whether they need assistance to remember to turn 
off appliances and lock doors. 
 
In Chapter 3 QEEG indices were averaged across regional planes of electrodes to identify regions 
of interest, this included: frontal polar (Fp1-Fp2), frontal (F7-F3-Fz-F4-F8), centrotemporal (T3-
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C3-Cz-C4-T4), parietotemporal (T5-P3-Pz-P4-T6) and occipital (O1-O2) planes.  This is similar to 
the frontal and posterior planes used in the Chapter 2 study, however, these measures are more 
thorough covering all 19 electrodes.  All electrodes were referenced to Cz to facilitate better 
potential clinical translation.  For example, if one plane of electrodes were of interest in screening 
for cognitive impairment just those few electrodes with the addition of one Cz reference electrode 
could be isolated; whereas in cases where CAR is used the results may be influenced by electrodes 
across the scalp.  The initial correlation analysis revealed that higher power in posterior, relative 
theta frequency, and lower posterior PAF across the scalp were associated with lower outcome 
MoCA scores, and thus greater degrees of cognitive impairment.  These two indices reflect slowing 
of the alpha frequency (discussed in detail below). Together these results suggest that slowing of 
alpha power is associated with subsequent cognitive impairment.  Using logistic regression 
modelling, occipital and central relative power in the upper theta frequency were identified as the 
best predictors of cognitive impairment and were able to accurately classify 81% of participants as 
to whether or not they had cognitive impairment at outcome.  A ROC analysis was used to 
determine the optimal cut-off values to classify impairments for each measure.  Occipital theta 
power was found to be more sensitive and specific when classifying patients than central theta 
power; hence this measure could be considered the primary QEEG measure of value (amongst those 
analysed) in relation to informing prognoses of post-stroke cognitive impairment. 
 
Pre-discharge MoCA scores assessed at the time of the EEG recording were also investigated in 
relation to cognitive impairment, in a separate model.  In those patients able to complete pre-
discharge MoCA, this score was able to correctly classify 92% of patients correctly.  Although the 
MoCA was slightly more accurate in a sub-sample than the posterior QEEG indices it was unable to 
be completed by all patients.  Thirteen percent of the patients recruited were unable to complete the 
pre-discharge MoCA due to functional impairments such as upper arm weakness and hemiplegia.  
All patients were however, able to be assessed with EEG.  That is, one of the advantages of using 
EEG as a screening measure is that it can be assessed regardless of the patient’s functional abilities 
or impairments in contrast to commonly used pen and paper assessments such as the MoCA, which 
can exclude substantial numbers of patients from assessments. 
 
Post-Stroke cognitive impairment and alpha frequency 
Due to the different cognitive assessments (The FIM-FAM vs the MoCA) and the regional QEEG 
measures assessed in the studies in Chapter 2 and 3 we would not expect identical results between 
the studies.  It was, however, found that a common theme emerged from both studies: relating to 
alpha power and alpha slowing and cognitive outcomes.  QEEG indices sensitive to alpha activity 
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and/or slowing, were found to be the most salient indices in relation to post-stroke cognitive 
outcomes in both chapters.  In Chapter 2, frontal DAR and global relative alpha frequency power 
were the QEEG indices of interest. In Chapter 3, posterior relative theta frequency power and 
frontal and posterior PAF were significantly related to subsequent cognitive impairment.  
 
As outlined above it is postulated that in Chapter 3, the relationship between MoCA scores and 
increased relative power in the classical theta frequency range is reflective of alpha slowing. 
Finnigan et al. (2011) suggest that “two forms of theta-frequency oscillations may exist; one 
indicative of healthy neurocognitive function and the other, EEG/alpha slowing linked to (future) 
substantial cognitive decline”.  That is, in clinical populations (as in the current study) increased 
power in the classical theta frequency band is actually reflective of alpha slowing and this is 
indicative of cognitive impairment/decline. Similarly, Moretti et al. (2004) identified slowing of 
alpha frequency power, including transition into the classical theta frequency band (≥5-7Hz) in 
group of 20 patients with vascular dementia (VaD), compared to 30 healthy participants (Moretti et 
al., 2004). In a later study Moretti et al. (2007) recorded EEG and rated the degree of age related 
white matter changes using MRI in 99 participants with MCI. Patients with no vascular damage had 
significantly higher transition frequencies (the frequency between alpha and theta power) than those 
with moderate and/or more severe damage.  Hence slowing of alpha power (lower theta alpha 
transition frequencies) appears to be sensitive to vascular brain injury in those with MCI.  These 
studies support the Finnigan et al. (2011) theory of pathological alpha slowing in patients with 
cognitive impairment and vascular injury and in turn the results of the Chapter 2 and 3 studies; the 
increased post-stroke power in the classical upper theta frequency is (at least in part) reflective of 
alpha slowing associated with greater levels of cognitive impairment. 
 
Muresanu et al. (2008) used measures of alpha slowing to index cognitive impairment in VaD as 
well as patients responses to the neurotrophic medication, cerebrolysin (Muresanu et al., 2008).  
Forty-one patients with VaD were randomised into treatment or placebo groups, EEG and cognitive 
function (assessed using the MMSE and the Alzheimer’s Disease scale-cog (ADAS-cog)) were 
assessed at baseline and following 4 weeks of treatment.  As expected and in line with the results 
reported in Chapter 3, increased theta power (indexing alpha slowing) was associated with 
decreased MMSE scores at baseline.  Along with an improvement in cognitive function, patients 
treated with cerebrolysin had significantly reduced degrees of EEG slowing measured using the 
DTABR (similar to DAR assessed in Chapter 2) between the baseline and outcome EEG 
recordings.  Improvements in cognitive performance occurred simultaneously with acceleration of 
EEG activity (reversal of slowing).  These findings indicate that measures of alpha slowing (for 
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example, theta frequency power) may be used to monitor responses to treatment of cognitive 
decline as a result of vascular injury and indicate a possible future direction for research in QEEG 
and post-stroke cognitive function. 
 
In addition lower PAF was significantly correlated with lower outcome MoCA scores (as outlined 
in Chapter3).  PAF is a measure of the frequency of the peak power within the upper theta and alpha 
frequency bands hence it is sensitive to alpha slowing; whereby lower PAF indicates greater degree 
of alpha slowing.  Lower PAF is common in individuals with brain injury (Angelakis et al., 2004).  
In addition PAF tends to be lower in stroke patients than healthy controls (Yuasa et al., 2001).  In 
21 stroke patients (mean time from stroke 8.4 years) living at home and 10 healthy volunteers, 
resting state EEG was recorded and participation in ADLs was assessed.  PAF was found to be 
significantly lower in the stroke group compared to healthy group as was the level of participation 
in ADLs (Yuasa et al., 2001).   
 
PAF also appears to be associated with cognitive domains particularly working memory and 
attention in healthy non-stroke populations. In 550 normal participants resting state PAF was found 
to be a significant predictor of performance in a forward and reverse digit span working memory 
task (Clark et al., 2004).  Higher PAF tended to reflect better performance in the working memory 
task (Clark et al., 2004).  Working memory is inter-related with other cognitive domains in 
particular, attention (Finnigan and Robertson, 2011).  Klimesch (2012) postulates that high resting 
power in the alpha frequency is an indicator of a well-developed attentional filter which acts to keep 
targeted or relevant information in focus.  The relationship between working memory and PAF 
reported in Clarke et al. (2004) may be modulated at least in part by attentional function.  The 
significant correlations between PAF and MoCA reported in Chapter 3 may be due in particular to 
the influence of working memory function and attention on both variables (PAF and MoCA) for 
example; working memory and attention are likely to contribute to performance in the sustained 
attention, the serial subtraction and digits forward and backward tasks of the MoCA. 
 
In addition post-stroke attentional capacity (assessed at two-months post-stroke) has been shown to 
independently correlate with general functional and motor activity outcomes, assessed at two years 
post stroke (Robertson et al., 1997).  Those authors postulate that sustained attention is integral to 
the learning-based recovery of functional and motor skills following stroke. The results of Chapter 
2 and 3 collectively indicate that alpha activity may index post-stroke attentional and working 
memory capacity which in turn appears to be a key determinant of functional cognitive outcomes 
from ischaemic stroke.  This model would explain the findings that QEEG indices of post-stroke 
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alpha activity – including slowed alpha activity – can significantly inform prognosis of cognitive 
outcomes from stroke. 
 
Post-stroke Depression and QEEG 
In addition to investigating the value of QEEG in screening for cognitive impairment the potential 
value of QEEG in relation to PSD was analysed as reported in Chapter 4.  A significant correlation 
was obtained between PSD and an index of interhemispheric asymmetry of delta activity.  
Specifically, higher degrees of interhemispheric symmetry in the delta frequency, between the left 
and right posterior temporal electrodes, was associated with relatively greater depressive symptoms 
at follow-up. However, in regression analysis, it was found that interhemispheric delta symmetry 
did not significantly contribute to the accurate prediction of PSD. 
 
In past studies delta frequency power in posterior brain regions was identified as potentially linked 
to PSD (Zhang et al., 2015).   They found that patients with PSD had significantly greater delta 
frequency power in frontal and central electrodes than post-stroke patients without depression and 
healthy controls (Zhang et al., 2015). It is interesting to note that increased symmetry-between left 
right temporal electrodes-was associated with greater levels of depression.  Typically studies of 
depression (in non-stroke samples) report increases in asymmetry to be associated with 
depression/depressive levels (Allen and Reznik, 2015); albeit the aforementioned study assessed 
frontal alpha rather than posterior delta asymmetry.  In addition a typical, moderate to severe stroke 
would show high delta asymmetry; at least frontally in MCA stroke.  Thus frontal delta asymmetry 
is generally associated with worse functional outcomes albeit not necessarily depression (Finnigan 
and van Putten, 2013).  In severe stroke it has been reported that high delta power is also observed 
over the contralateral hemisphere, within timeframes similar to the EEG recording in this study 
(Finnigan et al., 2008).  In these cases delta (a)symmetry may be influenced primarily by stroke 
severity and therefore lack the ability to indicate PSD. 
 
Further investigation into the role of QEEG indices in screening for PSD are warranted, especially 
in larger samples with greater power.  Although at this stage QEEG indices don’t appear to be 
accurate for screening of PSD, it is worthwhile noting that there are well documented links between 
PSD and cognitive impairment in stroke populations (Kauhanen et al., 1999). The significant 
findings between slowed alpha power and cognitive impairment reported in Chapter 2 and 3 may 
indicate that QEEG measures may be an optimal assessment of cognitive impairment and in turn 
indirectly indicate patients with increased risk of depression due to the documented association 
between PSD and cognitive impairment. 
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Clinical use of QEEG in pre-discharge stroke assessment 
The Canadian best practice guideline for Mood, Cognition and Fatigue Following Stroke outlines 
the value of early screening for both cognitive function and PSD (Eskes et al., 2015).  In particular 
they outline the importance of integrating screening and assessment practices into existing stroke 
protocols.  Accurate screening of common and less obvious impairments (for example, of higher 
order cognitive function in contrast to functional disability) can help inform planning, for example, 
in relation to return to work.  Patients who are not screened for potential cognitive impairment may 
not benefit from optimal decision making in relation to re-integration into the community, return to 
work or other outcomes or activities.  These types of patients as well as those who can’t complete 
cognitive screening (for example, MoCA) could benefit most from QEEG assessments. 
 
On the basis of the results reported here, QEEG appears to be a useful assessment tool to inform 
and enhance screening for and prognosis of post-stroke cognitive impairment.  The results of 
Chapter 3 suggest that just several posterior electrodes and a brief 3-minute EEG recording could 
help achieve these aims.  QEEG has various features beneficial to assessment of post-stroke 
patients.  It can be used at bed-side, rather than the patient having to be transported to the scanner as 
is the case with imaging methods such as MRI or CT.  In addition EEG systems are very 
inexpensive in comparison with imaging technology.  Modern EEG technology displays QEEG 
immediately at bedside.  EEG is virtually without contraindication as opposed to imaging (for 
example, pacemakers for MRI). In contrast to cognitive screens (for example, MoCA, MMSE) there 
are no restrictions on participation or completion due to stroke related language or functional 
impairments or patients not fluent in a given language.  The primary constraints for EEG are ready 
availability of expertise for electrode set-up and interpretation, which may, in part, be addressed by 
using brief recordings and a reduced number of electrodes (Chapter 3 and 4). 
 
In addition to cognitive impairment, QEEG measures have been linked to disability and functional 
outcomes following stroke.  Disability is twice as high in patients with post-stroke cognitive 
impairments as those without (Douiri et al., 2013) and associated with increased instances of 
dependent living (Tatemichi et al., 1994). Finnigan et al. (2013) report the value of QEEG in 
monitoring and assessing disability and functional outcomes in their recent comprehensive review. 
This gives further incentive to develop routine QEEG assessment protocols during the post-stroke, 
inpatient stay.  Not only could QEEG assessment lead to the identification of cognitive impairment, 
a risk factor for functional impairment, it may be useful for dual screening of disability and 
functional outcomes in addition. 
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Limitations 
The results of the studies in this thesis provide preliminary data which larger, well-funded studies 
can extend upon.  There is some limitation in relation to the sample sizes which may particularly 
have influenced the results of the depression study. For example PSD only affects approximately 
30% of post-stroke patients (supported by the results in Chapter 4) (Ayerbe et al., 2013) whereas 
cognitive impairments are more frequent (Pahlman et al., 2012, Qu et al., 2015) (supported by the 
results of Chapter 3).  It is very time and resource intensive to achieve recruitment of an adequate 
and relatively homogenous stroke patient (ischaemic MCA territory) sample.  In addition the 
retention of participants over the three-month follow-up period was in some cases challenging, due 
to the impact stroke had on patient’s functional abilities and (in)dependence including the ability to 
return to hospital follow-up appointments. 
 
Due to the nature of these studies, as the first comprehensive investigations into the assessment of 
post-stroke cognitive impairment and depression using QEEG, corrections for multiple comparisons 
were not consistently used throughout.  Hence these studies were relatively more exploratory and 
hypothesis generating (rather than hypothesis driven). Although there are certainly statisticians who 
support the use of stringent corrections for multiple comparisons, such as the Bonferroni technique, 
there are others who report that at best it is restrictive and at worst presents a bias towards type 2 
errors (Perneger, 1998).  Nonetheless it is important to note that such corrections were not used in 
Chapters 3 and 4 and as such the results of the analyses should be interpreted with some degree of 
caution. 
 
In addition it is important to consider that assessments such as the MoCA and the GDS are 
screening tools; they are not replacements for more systematic diagnostic tests such as those 
consistent with DSM-IV criteria and/or full neuropsychological assessment battery.  The MoCA 
and GDS are routinely used to screen for PSD and cognitive impairment so that the patient can be 
referred on to appropriate clinicians for more systematic and/or diagnostic and in depth assessment 
and potentially referral for rehabilitation and treatment.   
 
The results reported in this thesis include samples of MCA territory ischaemic stroke patients only. 
This group was chosen as it is likely the most prevalent types of stroke presentation.  Although the 
results of these studies may be reproducible in or generalisable to patients with other stroke types or 
locations (for example, posterior cerebral artery) this remains to be investigated. It would certainly 
be of interest and benefit to investigate such samples in future studies. 
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Summary and Conclusion 
Australian guidelines along with those of many other countries, such as Canada, recommend that all 
stroke patients be screened for cognitive impairment and depression following stroke (Australia., 
2010, Eskes et al., 2015).  Current screening assessments such as the MoCA cannot be performed 
(in full) by patients with functional and/or language impairments.  Whereas QEEG measures have 
the potential ability to inform and enhance accurate screening for (future) cognitive impairments in 
all patients, regardless of abilities and deficits. Indices sensitive to slowed alpha activity have the 
potential to be readily implemented into clinical assessments in stroke units to inform pre-discharge 
decisions and planning.  In addition they could be used to augment and/or enhance screening 
protocols in patients who are able to complete screening tools such as the MoCA. Future studies or 
trials can investigate this possibility more systematically. 
 
The results of the studies reported in Chapters 2 and 3 indicate that QEEG markers sensitive to 
alpha activity - and slowing of the same - can substantially inform prognoses of post-stroke 
cognitive impairment.  In particular, pre-discharge measures that assess the slowing of alpha power, 
such as power in the classical theta frequency range and PAF (across upper theta and alpha bands), 
can inform accurate prediction of cognitive impairment at approximately 3-months post-stroke.  
The former measure from posterior electrodes was able to accurately classify 81% (25/31) of 
patients as having cognitive impairment or not at, at follow-up.  Unlike other cognitive assessments 
such as the MoCA, QEEG can be acquired and analysed from all patients regardless of pre-existing 
or stroke related functional and language impairments.  In addition the optimal cut-off scores were 
identified for the identified posterior alpha slowing measures to classify patients as normative or 
cognitively impaired at follow-up (Chapter 3). 
 
Together with other results and proposals, these novel results indicate that markers of alpha activity 
- in the days after stroke - can inform accurate prognostication of cognitive outcomes, including in 
those patients who cannot be assessed with more routine cognitive screening tools.  This scenario 
appears to be mediated by attentional function which seems to be associated with both variables 
(alpha frequency and post-stroke outcomes). These results and interpretations constitute the 
principal contributions which this thesis makes to the knowledge base in this field.  Future studies 
or trials can build upon this work, toward implementation into clinical settings. Hence this research 
has potential to eventually provide important insights regarding brain dysfunction and cognitive 
outcomes, which can inform future clinical decisions regarding post-discharge scenarios, such as 
required levels of care, rehabilitation planning, or return to work. These insights would also inform 
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early consultations with patients’ families. Thereby, enhanced prognostication (informed by QEEG 
measures identified herein) would positively impact stroke patients and their families, and the 
broader community.  
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